1
|
Almeida VN. Somatostatin and the pathophysiology of Alzheimer's disease. Ageing Res Rev 2024; 96:102270. [PMID: 38484981 DOI: 10.1016/j.arr.2024.102270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2023] [Revised: 03/09/2024] [Accepted: 03/09/2024] [Indexed: 03/28/2024]
Abstract
Among the central features of Alzheimer's disease (AD) progression are altered levels of the neuropeptide somatostatin (SST), and the colocalisation of SST-positive interneurons (SST-INs) with amyloid-β plaques, leading to cell death. In this theoretical review, I propose a molecular model for the pathogenesis of AD based on SST-IN hypofunction and hyperactivity. Namely, hypofunctional and hyperactive SST-INs struggle to control hyperactivity in medial regions in early stages, leading to axonal Aβ production through excessive presynaptic GABAB inhibition, GABAB1a/APP complex downregulation and internalisation. Concomitantly, excessive SST-14 release accumulates near SST-INs in the form of amyloids, which bind to Aβ to form toxic mixed oligomers. This leads to differential SST-IN death through excitotoxicity, further disinhibition, SST deficits, and increased Aβ release, fibrillation and plaque formation. Aβ plaques, hyperactive networks and SST-IN distributions thereby tightly overlap in the brain. Conversely, chronic stimulation of postsynaptic SST2/4 on gulutamatergic neurons by hyperactive SST-INs promotes intense Mitogen-Activated Protein Kinase (MAPK) p38 activity, leading to somatodendritic p-tau staining and apoptosis/neurodegeneration - in agreement with a near complete overlap between p38 and neurofibrillary tangles. This model is suitable to explain some of the principal risk factors and markers of AD progression, including mitochondrial dysfunction, APOE4 genotype, sex-dependent vulnerability, overactive glial cells, dystrophic neurites, synaptic/spine losses, inter alia. Finally, the model can also shed light on qualitative aspects of AD neuropsychology, especially within the domains of spatial and declarative (episodic, semantic) memory, under an overlying pattern of contextual indiscrimination, ensemble instability, interference and generalisation.
Collapse
Affiliation(s)
- Victor N Almeida
- Institute of Psychiatry, Faculty of Medicine, University of São Paulo (USP), Brazil; Faculty of Languages, Federal University of Minas Gerais (UFMG), Brazil.
| |
Collapse
|
2
|
Cid REC, Ortega A, Visser U, Kitaigorodsky M, Zheng DD, Hincapie D, Crenshaw KH, Beaulieu A, Bosworth B, Gallardo L, Neer E, Ramirez S, Crocco EA, Georgiou M, Sfakianaki E, Loewenstein DA. The computerized LASSI-BC Test versus the Standard LASSI-L Paper-and-Pencil Version in Community-Based-Samples. ADVANCES IN ALZHEIMER'S DISEASE 2024; 13:11-25. [PMID: 39035045 PMCID: PMC11259231 DOI: 10.4236/aad.2024.131002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Indexed: 07/23/2024]
Abstract
Proactive Semantic Interference (PSI) and failure to recover from PSI (frPSI), are novel constructs assessed by the LASSI-L. These measures are sensitive to cognitive changes in early Mild Cognitive Impairment (MCI) and preclinical AD determined by Aβ load using PET. The goal of this study was to compare a new computerized version of the LASSI-L (LASSI-Brief Computerized) to the standard paper-and-pencil version of the test. In this study, we examined 110 cognitively unimpaired (CU) older adults and 79 with amnestic MCI (aMCI) who were administered the paper-and-pencil form of the LASSI-L. Their performance was compared with 62 CU older adults and 52 aMCI participants examined using the LASSI-BC. After adjustment for covariates (degree of initial learning, sex, education, and language of evaluation) both the standard and computerized versions distinguished between aMCI and CU participants. The performance of CU and aMCI groups using either form was relatively commensurate. Importantly, an optimal combination of Cued B2 recall and Cued B1 intrusions on the LASSI-BC yielded an area under the ROC curve of .927, a sensitivity of 92.3% and specificity of 88.1%, relative to an area under the ROC curve of .815, a sensitivity of 72.5%, and a specificity of 79.1% obtained for the paper-and-pencil LASSI-L. Overall, the LASSI-BC was comparable, and in some ways, superior to the paper-and-pencil LASSI-L. Advantages of the LASSI-BC include a more standardized administration, suitability for remote assessment, and an automated scoring mechanism that can be verified by a built-in audio recording of responses.
Collapse
Affiliation(s)
- Rosie E Curiel Cid
- Center for Cognitive Neuroscience and Aging and Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA
| | - Alexandra Ortega
- Center for Cognitive Neuroscience and Aging and Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA
| | - Ubbo Visser
- Department of Computer Sciences, University of Miami, Coral Gables, FL, USA
| | - Marcela Kitaigorodsky
- Center for Cognitive Neuroscience and Aging and Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA
| | - D Diane Zheng
- Center for Cognitive Neuroscience and Aging and Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA
| | - Diana Hincapie
- Center for Cognitive Neuroscience and Aging and Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA
| | - Kirsten Horne Crenshaw
- Center for Cognitive Neuroscience and Aging and Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA
| | | | - Brooke Bosworth
- Center for Cognitive Neuroscience and Aging and Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA
| | - Liz Gallardo
- Center for Cognitive Neuroscience and Aging and Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA
| | - Emory Neer
- Center for Cognitive Neuroscience and Aging and Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA
| | - Sofia Ramirez
- Center for Cognitive Neuroscience and Aging and Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA
| | - Elizabeth A Crocco
- Center for Cognitive Neuroscience and Aging and Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA
| | - Mike Georgiou
- Department of Computer Sciences, University of Miami, Coral Gables, FL, USA
| | - Efrosyni Sfakianaki
- Department of Radiology and Nuclear Medicine, Miller School of Medicine, University of Miami, Miami, FL, USA
| | - David A Loewenstein
- Center for Cognitive Neuroscience and Aging and Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA
| |
Collapse
|
3
|
Curiel Cid RE, Crocco EA, Duara R, Vaillancourt D, Asken B, Armstrong MJ, Adjouadi M, Georgiou M, Marsiske M, Wang WI, Rosselli M, Barker WW, Ortega A, Hincapie D, Gallardo L, Alkharboush F, DeKosky S, Smith G, Loewenstein DA. Different aspects of failing to recover from proactive semantic interference predicts rate of progression from amnestic mild cognitive impairment to dementia. Front Aging Neurosci 2024; 16:1336008. [PMID: 38357533 PMCID: PMC10864586 DOI: 10.3389/fnagi.2024.1336008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2023] [Accepted: 01/17/2024] [Indexed: 02/16/2024] Open
Abstract
Introduction This study investigated the role of proactive semantic interference (frPSI) in predicting the progression of amnestic Mild Cognitive Impairment (aMCI) to dementia, taking into account various cognitive and biological factors. Methods The research involved 89 older adults with aMCI who underwent baseline assessments, including amyloid PET and MRI scans, and were followed longitudinally over a period ranging from 12 to 55 months (average 26.05 months). Results The findings revealed that more than 30% of the participants diagnosed with aMCI progressed to dementia during the observation period. Using Cox Proportional Hazards modeling and adjusting for demographic factors, global cognitive function, hippocampal volume, and amyloid positivity, two distinct aspects of frPSI were identified as significant predictors of a faster decline to dementia. These aspects were fewer correct responses on a frPSI trial and a higher number of semantic intrusion errors on the same trial, with 29.5% and 31.6 % increases in the likelihood of more rapid progression to dementia, respectively. Discussion These findings after adjustment for demographic and biological markers of Alzheimer's Disease, suggest that assessing frPSI may offer valuable insights into the risk of dementia progression in individuals with aMCI.
Collapse
Affiliation(s)
- Rosie E. Curiel Cid
- Florida Alzheimer’s Disease Research Center, Miami, FL, United States
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, United States
| | - Elizabeth A. Crocco
- Florida Alzheimer’s Disease Research Center, Miami, FL, United States
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, United States
| | - Ranjan Duara
- Florida Alzheimer’s Disease Research Center, Miami, FL, United States
- Department of Neurology and The Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL, United States
| | - David Vaillancourt
- Florida Alzheimer’s Disease Research Center, Miami, FL, United States
- Department of Applied Physiology and Kinesiology, Gainesville, FL, United States
| | - Breton Asken
- Florida Alzheimer’s Disease Research Center, Miami, FL, United States
- Department of Applied Physiology and Kinesiology, Gainesville, FL, United States
| | - Melissa J. Armstrong
- Florida Alzheimer’s Disease Research Center, Miami, FL, United States
- University of Florida College of Medicine, Gainesville, FL, United States
| | - Malek Adjouadi
- Florida Alzheimer’s Disease Research Center, Miami, FL, United States
- Department of Clinical and Health Psychology, University of Florida, Miami, FL, United States
| | - Mike Georgiou
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, United States
| | - Michael Marsiske
- Florida Alzheimer’s Disease Research Center, Miami, FL, United States
- Department of Clinical and Health Psychology, University of Florida, Miami, FL, United States
| | - Wei-in Wang
- Florida Alzheimer’s Disease Research Center, Miami, FL, United States
- Department of Clinical and Health Psychology, University of Florida, Miami, FL, United States
| | - Monica Rosselli
- Florida Alzheimer’s Disease Research Center, Miami, FL, United States
- Department of Psychology, Florida Atlantic University, Boca Raton, FL, United States
| | - William W. Barker
- Florida Alzheimer’s Disease Research Center, Miami, FL, United States
- Wien Center for Alzheimer’s Disease and Memory Disorders, Mount Sinai Medical Center, Miami, FL, United States
| | - Alexandra Ortega
- Florida Alzheimer’s Disease Research Center, Miami, FL, United States
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, United States
| | - Diana Hincapie
- Florida Alzheimer’s Disease Research Center, Miami, FL, United States
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, United States
| | - Liz Gallardo
- Florida Alzheimer’s Disease Research Center, Miami, FL, United States
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, United States
| | - Feras Alkharboush
- Florida Alzheimer’s Disease Research Center, Miami, FL, United States
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, United States
| | - Steven DeKosky
- Florida Alzheimer’s Disease Research Center, Miami, FL, United States
- Department of Neurology and McKnight Brain Institute, University of Florida, Gainesville, FL, United States
| | - Glenn Smith
- Florida Alzheimer’s Disease Research Center, Miami, FL, United States
- Department of Clinical and Health Psychology, University of Florida, Miami, FL, United States
- Center for Advanced Technology and Education, Florida International University, Miami, FL, United States
| | - David A. Loewenstein
- Florida Alzheimer’s Disease Research Center, Miami, FL, United States
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, United States
| |
Collapse
|
4
|
Ramos AA, Galiano-Castillo N, Machado L. Cognitive Functioning of Unaffected First-degree Relatives of Individuals With Late-onset Alzheimer's Disease: A Systematic Literature Review and Meta-analysis. Neuropsychol Rev 2023; 33:659-674. [PMID: 36057684 PMCID: PMC10770217 DOI: 10.1007/s11065-022-09555-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2021] [Accepted: 06/10/2022] [Indexed: 10/14/2022]
Abstract
First-degree relatives of individuals with late-onset Alzheimer's disease (LOAD) are at increased risk for developing dementia, yet the associations between family history of LOAD and cognitive dysfunction remain unclear. In this quantitative review, we provide the first meta-analysis on the cognitive profile of unaffected first-degree blood relatives of LOAD-affected individuals compared to controls without a family history of LOAD. A systematic literature search was conducted in PsycINFO, PubMed /MEDLINE, and Scopus. We fitted a three-level structural equation modeling meta-analysis to control for non-independent effect sizes. Heterogeneity and risk of publication bias were also investigated. Thirty-four studies enabled us to estimate 218 effect sizes across several cognitive domains. Overall, first-degree relatives (n = 4,086, mean age = 57.40, SD = 4.71) showed significantly inferior cognitive performance (Hedges' g = -0.16; 95% CI, -0.25 to -0.08; p < .001) compared to controls (n = 2,388, mean age = 58.43, SD = 5.69). Specifically, controls outperformed first-degree relatives in language, visuospatial and verbal long-term memory, executive functions, verbal short-term memory, and verbal IQ. Among the first-degree relatives, APOE ɛ4 carriership was associated with more significant dysfunction in cognition (g = -0.24; 95% CI, -0.38 to -0.11; p < .001) compared to non-carriers (g = -0.14; 95% CI, -0.28 to -0.01; p = .04). Cognitive test type was significantly associated with between-group differences, accounting for 65% (R23 = .6499) of the effect size heterogeneity in the fitted regression model. No evidence of publication bias was found. The current findings provide support for mild but robust cognitive dysfunction in first-degree relatives of LOAD-affected individuals that appears to be moderated by cognitive domain, cognitive test type, and APOE ɛ4.
Collapse
Affiliation(s)
- Ari Alex Ramos
- Department of Psychology and Brain Health Research Centre, University of Otago, Dunedin, New Zealand.
- Brain Research New Zealand, Auckland, New Zealand.
- Department of Psychology, Pontifical Catholic University of Paraná, Rua Imaculada Conceição, 1155, Curitiba, CEP 80.215-901, Brazil.
| | - Noelia Galiano-Castillo
- Department of Physical Therapy, Health Sciences Faculty, "Cuidate" from Biomedical Group (BIO277), Instituto de Investigación Biosanitaria (ibs.GRANADA), and Sport and Health Research Center (IMUDs), Granada, Spain, University of Granada, Granada, Spain
| | - Liana Machado
- Department of Psychology and Brain Health Research Centre, University of Otago, Dunedin, New Zealand
- Brain Research New Zealand, Auckland, New Zealand
| |
Collapse
|
5
|
Hewawasam C, Wickramasinghe A, Caldera MC, Dassanayake TL. Subclinical memory impairment in unaffected siblings of patients with dementia. Clin Neuropsychol 2023; 37:1669-1685. [PMID: 36866972 DOI: 10.1080/13854046.2023.2182832] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2022] [Accepted: 02/15/2023] [Indexed: 03/04/2023]
Abstract
Objective: Family history of dementia is a known risk factor for dementia. The cognitive performance of unaffected siblings of dementia patients has been poorly studied. We aimed to determine whether clinically unaffected siblings of dementia patients have significant cognitive impairment compared to individuals who do not have first-degree relatives with dementia. Methods: We compared the cognitive performance of 67 patients with dementia (24 males; mean age 69.5), 90 healthy siblings of those patients (34 males; mean age 61.56) and 92 healthy adults (35 males; mean age 60.96) who have no first-degree relatives with dementia. We assessed learning and memory (Rey Auditory Verbal Learning Test (RAVLT)), short-term/working memory (Digit Span) executive functions (Stroop Test) and general intelligence (Raven Progressive Matrices). Test scores were compared among three groups, with regression-based adjustments for age, sex, and education. Results: As expected, the patients with dementia were impaired in all cognitive domains. In the Sibling Group, RAVLT total learning was significantly lower compared to controls (B = -3.192, p = .005). In a subgroup analysis, compared to controls, RAVLT delayed recall was poorer in the siblings of patients with early-onset (<65 years) dementia. No significant differences were observed in other cognitive domains. Conclusion: Clinically unaffected siblings of dementia patients seem to have a selective subclinical impairment in memory encoding. This impairment seems to be more prominent in siblings of patients with early-onset dementia who also have deficits in delayed recall. Future studies are needed to determine if the observed cognitive impairment deteriorates to dementia.
Collapse
Affiliation(s)
- Chandana Hewawasam
- Department of Physiology, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura, Sri Lanka
| | - Anuprabha Wickramasinghe
- Department of Psychiatry, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura, Sri Lanka
- Department of Psychiatry, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka
| | - Manjula C Caldera
- Neurology Unit, Teaching Hospital Anuradhapura, Anuradhapura, Sri Lanka
| | - Tharaka L Dassanayake
- Department of Physiology, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka
- School of Psychological Sciences, The University of Newcastle, Callaghan, NSW, Australia
| |
Collapse
|
6
|
Curiel Cid RE, Ortega A, Crocco EA, Hincapie D, McFarland KN, Duara R, Vaillancourt D, DeKosky ST, Smith G, Sfakianaki E, Rosselli M, Barker WW, Adjouadi M, Barreto Y, Feito Y, Loewenstein DA. Semantic intrusion errors are associated with plasma Ptau-181 among persons with amnestic mild cognitive impairment who are amyloid positive. Front Neurol 2023; 14:1179205. [PMID: 37602238 PMCID: PMC10436611 DOI: 10.3389/fneur.2023.1179205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2023] [Accepted: 07/06/2023] [Indexed: 08/22/2023] Open
Abstract
Introduction Semantic intrusion errors (SI) have distinguished between those with amnestic Mild Cognitive Impairment (aMCI) who are amyloid positive (A+) versus negative (A-) on positron emission tomography (PET). Method This study examines the association between SI and plasma - based biomarkers. One hundred and twenty-eight participants received SiMoA derived measures of plasma pTau-181, ratio of two amyloid-β peptide fragments (Aβ42/Aβ40), Neurofilament Light protein (NfL), Glial Fibrillary Acidic Protein (GFAP), ApoE genotyping, and amyloid PET imaging. Results The aMCI A+ (n = 42) group had a higher percentage of ApoE ɛ4 carriers, and greater levels of pTau-181 and SI, than Cognitively Unimpaired (CU) A- participants (n = 25). CU controls did not differ from aMCI A- (n = 61) on plasma biomarkers or ApoE genotype. Logistic regression indicated that ApoE ɛ4 positivity, pTau-181, and SI were independent differentiating predictors (Correct classification = 82.0%; Sensitivity = 71.4%; Specificity = 90.2%) in identifying A+ from A- aMCI cases. Discussion A combination of plasma biomarkers, ApoE positivity and SI had high specificity in identifying A+ from A- aMCI cases.
Collapse
Affiliation(s)
- Rosie E. Curiel Cid
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, United States
| | - Alexandra Ortega
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, United States
| | - Elizabeth A. Crocco
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, United States
| | - Diana Hincapie
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, United States
| | - Karen N. McFarland
- Department of Neurology and the Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL, United States
| | - Ranjan Duara
- Department of Neurology and the Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL, United States
| | - David Vaillancourt
- Department of Applied Physiology and Kinesiology, Gainesville, FL, United States
| | - Steven T. DeKosky
- Department of Neurology and McKnight Brain Institute, University of Florida, Gainesville, FL, United States
| | - Glenn Smith
- Department of Clinical and Health Psychology, University of Florida, Gainesville, FL, United States
| | - Efrosyni Sfakianaki
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, United States
| | - Monica Rosselli
- Department of Psychology, Florida Atlantic University, Boca Raton, FL, United States
| | - Warren W. Barker
- Wien Center for Alzheimer’s Disease and Memory Disorders, Mount Sinai Medical Center, Miami, FL, United States
| | - Malek Adjouadi
- Center for Advanced Technology and Education, Florida International University, Miami, FL, United States
| | - Yarlenis Barreto
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, United States
| | - Yuleidys Feito
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, United States
| | - David A. Loewenstein
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, United States
| |
Collapse
|
7
|
Chasles MJ, Joubert S, Cole J, Delage E, Et Rouleau I. Learning and vulnerability to phonological and semantic interference in normal aging: an experimental study. Memory 2023; 31:297-314. [PMID: 36475538 DOI: 10.1080/09658211.2022.2154366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
ABSTRACTThis study compares semantic and phonological interference vulnerability across the full range of learning processes. Method: 43 controls aged 61-88 underwent a neuropsychological examination, French adaptation of the LASSI-L, and an experimental phonological test, the TIP-A. Paired sample t-tests, factorial ANOVA and hierarchical regressions were conducted, psychometric properties were calculated. Results: TIP-A efficiently generated phonological interference between concurrent word lists and was associated with short-term memory, unlike LASSI-L. On LASSI-L, proactive interference was higher than retroactive interference; the opposite pattern was found on TIP-A. Memory performance was better explained by age in the semantic than in the phonological task. Age was not associated with interference vulnerability. Intrusions and false recognition were associated with cognitive functioning regardless of age, particularly in the semantic context. Conclusion: To our knowledge, this is the first study to assess phonological and semantic interference using homologous concurrent word list tasks, and not a working memory build-up or DRM paradigm. The pattern obtained illustrates the weak initial memory trace in a phonological context and results are discussed according to depth-of-processing and dual-process theories. Similar paradigms could be studied among various pathologies for a better understanding of generalised interference vulnerability vs. specific semantic or phonological impairment.
Collapse
Affiliation(s)
- M-J Chasles
- Psychology department, Université du Québec à Montréal (UQAM), Montréal, Canada.,Centre de recherche de l'Institut Universitaire de Gériatrie de Montréal (CRIUGM), Montréal, Canada
| | - S Joubert
- Centre de recherche de l'Institut Universitaire de Gériatrie de Montréal (CRIUGM), Montréal, Canada.,Psychology Department, Université de Montréal, Montréal, Canada
| | - J Cole
- Psychology department, Université du Québec à Montréal (UQAM), Montréal, Canada.,Centre de recherche de l'Institut Universitaire de Gériatrie de Montréal (CRIUGM), Montréal, Canada
| | - E Delage
- Centre de recherche de l'Institut Universitaire de Gériatrie de Montréal (CRIUGM), Montréal, Canada.,Psychology Department, Université de Montréal, Montréal, Canada
| | - I Et Rouleau
- Psychology department, Université du Québec à Montréal (UQAM), Montréal, Canada.,Centre Hospitalier de l'Université de Montréal (CHUM) research center, Montréal, Canada
| |
Collapse
|
8
|
Dhungana A, Becchi S, Leake J, Morris G, Avgan N, Balleine BW, Vissel B, Bradfield LA. Goal-Directed Action Is Initially Impaired in a hAPP-J20 Mouse Model of Alzheimer's Disease. eNeuro 2023; 10:ENEURO.0363-22.2023. [PMID: 36650070 PMCID: PMC9927544 DOI: 10.1523/eneuro.0363-22.2023] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2022] [Revised: 12/12/2022] [Accepted: 01/03/2023] [Indexed: 01/19/2023] Open
Abstract
Cognitive-behavioral testing in preclinical models of Alzheimer's disease has failed to capture deficits in goal-directed action control. Here, we provide the first comprehensive investigation of goal-directed action in a transgenic mouse model of Alzheimer's disease. Specifically, we tested outcome devaluation performance in male and female human amyloid precursor protein (hAPP)-J20 mice. Mice were first trained to press left and right levers for pellet and sucrose outcomes, respectively (counterbalanced), over 4 d. On test, mice were prefed one of the outcomes to satiety and given a choice between levers. Devaluation performance was intact for 36-week-old wild-types of both sexes, who responded more on the valued relative to the devalued lever (Valued > Devalued). By contrast, devaluation was impaired (Valued = Devalued) for J20 mice of both sexes, and for 52-week-old male mice regardless of genotype. After additional lever press training (i.e., 8-d lever pressing in total), devaluation was intact for all mice, demonstrating that the initial deficits were not a result of a nonspecific impairment in reward processing, depression, or locomotor activity in J20 or aging mice. Follow-up analyses revealed that microglial expression in the dorsal CA1 region of the hippocampus was associated with poorer outcome devaluation performance on initial, but not later tests. Together, these data demonstrate that goal-directed action is initially impaired in J20 mice of both sexes and in aging male mice regardless of genotype, and that this impairment is related to neuroinflammation in the dorsal CA1 hippocampal region.
Collapse
Affiliation(s)
- Amolika Dhungana
- School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, New South Wales 2007, Australia
- Centre for Neuroscience and Regenerative Medicine, St. Vincent's Centre for Applied Medical Research, St. Vincent's Health Network, Sydney, New South Wales 2010, Australia
| | - Serena Becchi
- School of Psychology, University of New South Wales Sydney, Sydney, New South Wales 2052, Australia
| | - Jessica Leake
- School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, New South Wales 2007, Australia
- Centre for Neuroscience and Regenerative Medicine, St. Vincent's Centre for Applied Medical Research, St. Vincent's Health Network, Sydney, New South Wales 2010, Australia
- School of Psychology, University of New South Wales Sydney, Sydney, New South Wales 2052, Australia
| | - Gary Morris
- School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, New South Wales 2007, Australia
- Centre for Neuroscience and Regenerative Medicine, St. Vincent's Centre for Applied Medical Research, St. Vincent's Health Network, Sydney, New South Wales 2010, Australia
- Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, Tasmania 7000, Australia
| | - Nesli Avgan
- Centre for Neuroscience and Regenerative Medicine, St. Vincent's Centre for Applied Medical Research, St. Vincent's Health Network, Sydney, New South Wales 2010, Australia
| | - Bernard W Balleine
- Decision Neuroscience Laboratory, School of Psychology, University of New South Wales Sydney, Sydney, New South Wales 2052, Australia
| | - Bryce Vissel
- Centre for Neuroscience and Regenerative Medicine, St. Vincent's Centre for Applied Medical Research, St. Vincent's Health Network, Sydney, New South Wales 2010, Australia
- School of Clinical Medicine, University of New South Wales Medicine & Health, St Vincent's Healthcare Clinical Campus, Faculty of Medicine and Health, University of New South Wales Sydney, Sydney, New South Wales 2052, Australia
| | - Laura A Bradfield
- School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, New South Wales 2007, Australia
- Centre for Neuroscience and Regenerative Medicine, St. Vincent's Centre for Applied Medical Research, St. Vincent's Health Network, Sydney, New South Wales 2010, Australia
| |
Collapse
|
9
|
Zheng DD, Cid REC, Duara R, Kitaigorodsky M, Crocco E, Loewenstein DA. Semantic intrusion errors as a function of age, amyloid, and volumetric loss: a confirmatory path analysis. Int Psychogeriatr 2022; 34:991-1001. [PMID: 33455613 PMCID: PMC11167622 DOI: 10.1017/s1041610220004007] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
OBJECTIVE To examine the direct and indirect effects of age, APOE ϵ4 genotype, amyloid positivity, and volumetric reductions in AD-prone brain regions as it relates to semantic intrusion errors reflecting proactive semantic interference (PSI) and the failure to recover from proactive semantic interference (frPSI) on the Loewenstein-Acevedo Scales of Semantic Interference and Learning (LASSI-L), a cognitive stress test that has been consistently more predictive of preclinical and prodromal Alzheimer's disease (AD) than traditional list-learning tests. DESIGN Cross-sectional study. SETTING 1Florida Alzheimer's Disease Research Center baseline study. PARTICIPANTS Two-hundred and twelve participants with Mini-Mental State Examination (MMSE) score above 16 and a broad array of cognitive diagnoses ranging from cognitively normal (CN) to dementia, of whom 58% were female, mean age of 72.1 (SD 7.9). MEASURES Participants underwent extensive clinical and neuropsychological evaluations, MR and amyloid Positron Emission Tomography/Computer/Computer Tomography (PET/CT) imaging, and analyses of APOE ϵ4 genotype. Confirmatory path analyses were conducted in the structural equation modeling framework that estimated multiple equations simultaneously while controlling for important covariates such as sex, education, language of evaluation, and global cognitive impairment. RESULTS Both amyloid positivity and decreased brain volumes in AD-prone regions were directly related to LASSI-L Cued B1 and Cued B2 intrusions (sensitive to PSI and frPSI effects) even after controlling for covariates. APOE ϵ4 status did not evidence direct effects on these LASSI-L cognitive markers, but rather exerted their effects on amyloid positivity, which in turn related to PSI and frPSI. Similarly, age did not have a direct relationship with LASSI-L scores, but exerted its effects indirectly through amyloid positivity and volumes of AD-prone brain regions. CONCLUSIONS Our study provides insight into the relationships among age, APOE ϵ4, amyloid, and brain volumetric reductions as it relates to semantic intrusion errors. The investigation expands our understanding of the underpinnings of PSI and frPSI intrusions in a large cohort.
Collapse
Affiliation(s)
- D. Diane Zheng
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA
| | - Rosie E. Curiel Cid
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA
- 1 Florida Alzheimer’s Disease Research Center, Miami Beach, FL, USA
| | - Ranjan Duara
- 1 Florida Alzheimer’s Disease Research Center, Miami Beach, FL, USA
- Wien Center for Alzheimer’s Disease and Memory Disorders, Mount Sinai Medical Center, Miami Beach, FL, USA
| | - Marcela Kitaigorodsky
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA
| | - Elizabeth Crocco
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA
| | - David A. Loewenstein
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA
- 1 Florida Alzheimer’s Disease Research Center, Miami Beach, FL, USA
| |
Collapse
|
10
|
Valles-Salgado M, Cabrera-Martín MN, Curiel-Cid RE, Delgado-Álvarez A, Delgado-Alonso C, Gil-Moreno MJ, Matías-Guiu J, Loewenstein DA, Matias-Guiu JA. Neuropsychological, Metabolic, and Connectivity Underpinnings of Semantic Interference Deficits Using the LASSI-L. J Alzheimers Dis 2022; 90:823-840. [PMID: 36189601 DOI: 10.3233/jad-220754] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
BACKGROUND LASSI-L is a novel neuropsychological test specifically designed for the early diagnosis of Alzheimer's disease (AD) based on semantic interference. OBJECTIVE To examine the cognitive and neural underpinnings of the failure to recover from proactive semantic and retroactive semantic interference. METHODS One hundred and fifty-five patients consulting for memory loss were included. Patients underwent neuropsychological assessment, including the LASSI-L, and FDG-PET imaging. They were categorized as subjective memory complaints (SMC) (n=32), pre-mild cognitive impairment (MCI) due to AD (Pre-MCI) (n=39), MCI due to AD (MCI-AD) (n=71), and MCI without evidence of neurodegeneration (MCI-NN) (n=13). Voxel-based brain mapping and metabolic network connectivity analyses were conducted. RESULTS A significant group effect was found for all the LASSI-L scores. LASSI-L scores measuring failure to recover from proactive semantic interference and retroactive semantic interference were predicted by other neuropsychological tests with a precision of 64.1 and 44.8%. The LASSI-L scores were associated with brain metabolism in the bilateral precuneus, superior, middle and inferior temporal gyri, fusiform, angular, superior and inferior parietal lobule, superior, middle and inferior occipital gyri, lingual gyrus, and posterior cingulate. Connectivity analysis revealed a decrease of node degree and centrality in posterior cingulate in patients showing frPSI. CONCLUSION Episodic memory dysfunction and the involvement of the medial temporal lobe, precuneus and posterior cingulate constitute the basis of the failure to recover from proactive semantic interference and retroactive semantic interference. These findings support the role of the LASSI-L in the detection, monitoring and outcome prediction during the early stages of AD.
Collapse
Affiliation(s)
- María Valles-Salgado
- Department of Neurology, Hospital Clínico San Carlos, San Carlos Health Research Institute (IdISSC), Universidad Complutense de Madrid, Madrid, Spain
| | - María Nieves Cabrera-Martín
- Department of Nuclear Medicine, Hospital Clínico San Carlos, San Carlos Health Research Institute (IdISSC), Universidad Complutense de Madrid, Madrid, Spain
| | - Rosie E Curiel-Cid
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami and Center of Aging, Miami, FL, USA
| | - Alfonso Delgado-Álvarez
- Department of Neurology, Hospital Clínico San Carlos, San Carlos Health Research Institute (IdISSC), Universidad Complutense de Madrid, Madrid, Spain
| | - Cristina Delgado-Alonso
- Department of Neurology, Hospital Clínico San Carlos, San Carlos Health Research Institute (IdISSC), Universidad Complutense de Madrid, Madrid, Spain
| | - María José Gil-Moreno
- Department of Neurology, Hospital Clínico San Carlos, San Carlos Health Research Institute (IdISSC), Universidad Complutense de Madrid, Madrid, Spain
| | - Jorge Matías-Guiu
- Department of Neurology, Hospital Clínico San Carlos, San Carlos Health Research Institute (IdISSC), Universidad Complutense de Madrid, Madrid, Spain
| | - David A Loewenstein
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami and Center of Aging, Miami, FL, USA
| | - Jordi A Matias-Guiu
- Department of Neurology, Hospital Clínico San Carlos, San Carlos Health Research Institute (IdISSC), Universidad Complutense de Madrid, Madrid, Spain
| |
Collapse
|
11
|
Loewenstein DA, Cid REC, Kitaigorodsky M, Ortega A, Hincapie D, Zheng DD, Amaya A, Gallardo L, Manso L, Sosa J, Crocco EA. Persistent Failure to Recover from Proactive Semantic Interference on the Cognitive Stress Test Differentiates Between Amnestic Mild Cognitive Impairment, Pre-Mild Cognitive Impairment, and Cognitively Unimpaired Older Adults. J Alzheimers Dis 2022; 90:313-322. [PMID: 36155503 PMCID: PMC11187974 DOI: 10.3233/jad-220348] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
BACKGROUND Susceptibility to proactive semantic interference (PSI) and the inability to ameliorate these difficulties with one additional learning trial have repeatedly been implicated as early features of incipient Alzheimer's disease (AD). Unfortunately, persistent failure to recover from PSI (frPSI) after repeated learning trials, are not captured by existing memory measures, or been examined in pre-mild cognitive impairment (PreMCI). OBJECTIVE A novel Cognitive Stress Test (CST) was employed to measure the impact of PSI, initial failure to recover from PSI and persistent effects of PSI, despite multiple learning trials of the new to-be-remembered material (pfrPSI). We hypothesized that PSI deficits on the CST would persist in both PreMCI and amnestic MCI (aMCI) groups over repeated learning trials when compared to cognitively unimpaired (CU) older adults. METHODS One hundred fifty older adults (69 CU, 31 PreMCI, and 50 aMCI) underwent a standardized clinical and neuropsychological evaluation. The CST was independent of diagnostic classification. RESULTS Even after adjusting for strength of initial learning, aMCI and PreMCI groups demonstrated greater persistent PSI (pfrPSI) relative to the CU group despite repeated learning trials of List B. Further, the aMCI group made a higher number of semantic intrusion errors relative to the PreMCI and CU groups on all List B Cued Recall trials. CONCLUSION Persistent PSI appears to be a common feature of aMCI and PreMCI. The possible theoretical mechanisms and empirical implications of these new findings are discussed.
Collapse
Affiliation(s)
- David A. Loewenstein
- Center for Cognitive Neuroscience and Aging and Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA
| | - Rosie E. Curiel Cid
- Center for Cognitive Neuroscience and Aging and Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA
| | - Marcela Kitaigorodsky
- Center for Cognitive Neuroscience and Aging and Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA
| | - Alexandra Ortega
- Center for Cognitive Neuroscience and Aging and Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA
| | - Diana Hincapie
- Center for Cognitive Neuroscience and Aging and Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA
| | - D. Diane Zheng
- Center for Cognitive Neuroscience and Aging and Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA
| | - Alexandra Amaya
- Center for Cognitive Neuroscience and Aging and Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA
| | - Liz Gallardo
- Center for Cognitive Neuroscience and Aging and Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA
| | - Leslie Manso
- Center for Cognitive Neuroscience and Aging and Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA
| | - Jaylene Sosa
- Center for Cognitive Neuroscience and Aging and Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA
| | - Elizabeth A. Crocco
- Center for Cognitive Neuroscience and Aging and Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA
| |
Collapse
|
12
|
Cid REC, Loewenstein DA. Salient Cognitive Paradigms to Assess Preclinical Alzheimer's Disease. Neurotherapeutics 2022; 19:89-98. [PMID: 35246818 PMCID: PMC9130422 DOI: 10.1007/s13311-022-01192-0] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/17/2022] [Indexed: 01/03/2023] Open
Abstract
Despite the growing emphasis to identify early biological markers that can detect the progressive accumulation of brain pathology in the complex pathophysiologic cascade that occurs in Alzheimer's disease (AD), we continue to employ the same neuropsychological paradigms that were developed to detect dementia or frank cognitive impairment. It has become increasingly clear that we cannot expect to measure clinically meaningful change in relationship to these emerging preclinical biomarkers using these traditional cognitive assessment paradigms, nor will we advance the efforts to identify the earliest cognitive changes that emerge in AD. Over the last decade, a few novel promising cognitive assessment paradigms have emerged that have shown promise in identifying subtle cognitive deficits in AD which aids in early detection and monitoring of meaningful cognitive change over time. Some of these cognitive assessment paradigms are reviewed here, including semantic interference, semantic intrusion errors, memory binding, and binding of face and name associations. These paradigms may be useful for AD clinical trials focused on secondary prevention if there is sufficient rigor to suggest that they correlate with AD biomarkers, having robust sensitivity, specificity, and predictive utility among culturally and linguistically diverse populations at-risk for AD.
Collapse
Affiliation(s)
- Rosie E Curiel Cid
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, 1695 NW 9th Avenue, Florida, Miami, 33136, USA.
| | - David A Loewenstein
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, 1695 NW 9th Avenue, Florida, Miami, 33136, USA
| |
Collapse
|
13
|
Kitaigorodsky M, Curiel Cid RE, Crocco E, Gorman KL, González-Jiménez CJ, Greig-Custo M, Barker WW, Duara R, Loewenstein DA. Changes in LASSI-L performance over time among older adults with amnestic MCI and amyloid positivity: A preliminary study. J Psychiatr Res 2021; 143:98-105. [PMID: 34464879 PMCID: PMC8557121 DOI: 10.1016/j.jpsychires.2021.08.033] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/22/2021] [Revised: 08/16/2021] [Accepted: 08/19/2021] [Indexed: 10/20/2022]
Abstract
There is a pressing need to develop measures that are sensitive to the earliest subtle cognitive changes of Alzheimer's disease (AD) to improve early detection and track disease progression. The Loewenstein-Acevedo Scales of Semantic Interference (LASSI-L) has been shown to successfully discriminate between cognitively unimpaired (CU) older adults and those with amnestic mild cognitive impairment (MCI) and to correlate with total and regional brain amyloid load. The present study investigated how the LASSI-L scores change over time among three distinct diagnostic groups. Eighty-six community-dwelling older adults underwent a baseline evaluation including: a clinical interview, a neuropsychological evaluation, Magnetic Resonance Imaging (MRI), and amyloid Positron Emission Tomography (PET). A follow up evaluation was conducted 12 months later. Initial mean values were calculated using one-way ANOVAs and chi-square analyses. Post-hoc comparisons were conducted using Tukey's Honestly Significant Difference (HSD). A 3 × 2 repeated measures analysis was utilized to examine differences in LASSI-L performance over time. The MCI amyloid positive group demonstrated a significantly greater decline in LASSI-L performance than the MCI amyloid negative and CU groups respectively. The scales that best differentiated the three groups included the Cued A2, which taps into maximum learning capacity, and Cued B2, which assesses the failure to recover from proactive semantic interference. Our findings further support the LASSI-L's discriminative validity.
Collapse
Affiliation(s)
| | | | - Elizabeth Crocco
- Psychiatry and Behavioral Sciences, University of Miami, Miami, FL, USA
| | | | | | - Maria Greig-Custo
- Wien Center for Alzheimer's Disease & Memory Disorders, Mount Sinai Medical Center, Miami Beach, FL, USA
| | - Warren W Barker
- Wien Center for Alzheimer's Disease & Memory Disorders, Mount Sinai Medical Center, Miami Beach, FL, USA
| | - Ranjan Duara
- Wien Center for Alzheimer's Disease & Memory Disorders, Mount Sinai Medical Center, Miami Beach, FL, USA
| | - David A Loewenstein
- Psychiatry and Behavioral Sciences, University of Miami, Miami, FL, USA; Wien Center for Alzheimer's Disease & Memory Disorders, Mount Sinai Medical Center, Miami Beach, FL, USA
| |
Collapse
|
14
|
Duarte-Abritta B, Sánchez SM, Abulafia C, Gustafson DR, Vázquez S, Sevlever G, Castro MN, Fiorentini L, Villarreal MF, Guinjoan SM. Amyloid and anatomical correlates of executive functioning in middle-aged offspring of patients with late-onset Alzheimer's disease. Psychiatry Res Neuroimaging 2021; 316:111342. [PMID: 34365076 DOI: 10.1016/j.pscychresns.2021.111342] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/31/2020] [Revised: 05/02/2021] [Accepted: 06/18/2021] [Indexed: 12/13/2022]
Abstract
A traditional hallmark of cognitive impairment associated with late-onset Alzheimer´s disease (LOAD) is episodic memory impairment. However, early alterations have been identified in brain regions associated with executive function in asymptomatic, middle-age offspring of patients with LOAD (O-LOAD) compared to those with no family history. We hypothesized that executive function among O-LOAD would correlate with structural and amyloid brain imaging differently from those without a family history of LOAD (control subjects, CS). Executive function, cortical thickness, and in-vivo Aβ deposits were quantified in 30 O-LOAD and 25 CS. Associations were observed among O-LOAD only. Cortical thickness in the left lateral orbitofrontal cortex was positively associated with Design Fluency. The Stroop Color and Word Test, correlated positively with right rostral mid-frontal cortex thickness. Trails Making Test-B was inversely related to left medial orbitofrontal thickness. Tower of London total time was positively associated with β-amyloid deposition in the right precuneus. These results support previous evidence that early executive dysfunction might reflect subtle, early changes in persons at risk of LOAD and suggests that executive function alterations deserve further exploration in the LOAD literature.
Collapse
Affiliation(s)
- Bárbara Duarte-Abritta
- Grupo de Investigación en Neurociencias Aplicadas a las Alteraciones de la Conducta, Instituto de Neurociencias FLENI-CONICET, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina
| | - Stella-Maris Sánchez
- Grupo de Investigación en Neurociencias Aplicadas a las Alteraciones de la Conducta, Instituto de Neurociencias FLENI-CONICET, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina; Departamento de Física, Facultad de Cs. Exactas y Naturales, Universidad de Buenos Aires, Argentina
| | - Carolina Abulafia
- Grupo de Investigación en Neurociencias Aplicadas a las Alteraciones de la Conducta, Instituto de Neurociencias FLENI-CONICET, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina; Institute for Biomedical Research (BIOMED), Pontifical Catholic University of Argentina, Buenos Aires, Argentina
| | - Deborah R Gustafson
- Department of Neurology, State University of New York University Downstate Health Sciences University, United States
| | - Silvia Vázquez
- Centro de imágenes moleculares (CIM), Fundación FLENI, Argentina
| | - Gustavo Sevlever
- Departamento de Neuropatología y Biología Molecular, Fundación FLENI, Buenos Aires, Argentina
| | - Mariana N Castro
- Grupo de Investigación en Neurociencias Aplicadas a las Alteraciones de la Conducta, Instituto de Neurociencias FLENI-CONICET, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina; Departamento de Salud Mental, Facultad de Medicina, Universidad de Buenos Aires, Argentina; Servicio de Psiquiatría, Fundación FLENI, Buenos Aires, Argentina
| | - Leticia Fiorentini
- Grupo de Investigación en Neurociencias Aplicadas a las Alteraciones de la Conducta, Instituto de Neurociencias FLENI-CONICET, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina; Servicio de Psiquiatría, Fundación FLENI, Buenos Aires, Argentina
| | - Mirta F Villarreal
- Grupo de Investigación en Neurociencias Aplicadas a las Alteraciones de la Conducta, Instituto de Neurociencias FLENI-CONICET, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina; Departamento de Física, Facultad de Cs. Exactas y Naturales, Universidad de Buenos Aires, Argentina
| | - Salvador M Guinjoan
- Grupo de Investigación en Neurociencias Aplicadas a las Alteraciones de la Conducta, Instituto de Neurociencias FLENI-CONICET, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina; Departamento de Fisiología, Facultad de Medicina, Universidad de Buenos Aires, Argentina; Departamento de Salud Mental, Facultad de Medicina, Universidad de Buenos Aires, Argentina; Neurofisiología I, Facultad de Psicología, Universidad de Buenos Aires, Argentina; Laureate Institute for Brain Research, OK, United States.
| |
Collapse
|
15
|
Kitaigorodsky M, Crocco E, Curiel‐Cid RE, Leal G, Zheng D, Eustache MK, Greig‐Custo MT, Barker W, Duara R, Loewenstein DA. The relationship of semantic intrusions to different etiological subtypes of MCI and cognitively healthy older adults. ALZHEIMER'S & DEMENTIA (AMSTERDAM, NETHERLANDS) 2021; 13:e12192. [PMID: 34084887 PMCID: PMC8144934 DOI: 10.1002/dad2.12192] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 12/16/2020] [Revised: 03/23/2021] [Accepted: 03/30/2021] [Indexed: 01/23/2023]
Abstract
INTRODUCTION There is increasing evidence that susceptibility to proactive semantic interference (PSI) and the failure to recover from PSI (frPSI) as evidenced by intrusion errors may be early cognitive markers of both preclinical and prodromal Alzheimer's disease (AD). METHODS One hundred forty-five participants were administered extensive clinical and neuropsychological evaluations including the Loewenstein-Acevedo Scales for Semantic Interference and Learning (LASSI-L), a sensitive cognitive stress test measuring PSI and frPSI. Participants also underwent structural magnetic resonance imaging (MRI) and amyloid positron emission tomography/computed tomography (PET/CT) imaging. RESULTS PSI and frPSI errors were much more prevalent in the mild cognitive impairment (MCI)-AD (amyloid positive) group than the other diagnostic groups. The number of intrusion errors observed across the other MCI groups without amyloid pathology and those with normal cognition were comparable. DISCUSSION Semantic intrusion errors on the LASSI-L occur much less frequently in persons who have different types of non-AD-related MCI and may be used as an early cognitive marker of prodromal AD.
Collapse
Affiliation(s)
- Marcela Kitaigorodsky
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral SciencesUniversity of Miami Miller School of MedicineMiamiUSA
| | - Elizabeth Crocco
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral SciencesUniversity of Miami Miller School of MedicineMiamiUSA
| | - Rosie E. Curiel‐Cid
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral SciencesUniversity of Miami Miller School of MedicineMiamiUSA
- 1Florida Alzheimer's Disease Research CenterGainesvilleFloridaUSA
| | - Giselle Leal
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral SciencesUniversity of Miami Miller School of MedicineMiamiUSA
| | - Diane Zheng
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral SciencesUniversity of Miami Miller School of MedicineMiamiUSA
| | - Melissa K. Eustache
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral SciencesUniversity of Miami Miller School of MedicineMiamiUSA
| | - Maria T. Greig‐Custo
- 1Florida Alzheimer's Disease Research CenterGainesvilleFloridaUSA
- Wien Center for Alzheimer's Disease and Memory DisordersMount Sinai, Medical CenterNew YorkUSA
| | - William Barker
- 1Florida Alzheimer's Disease Research CenterGainesvilleFloridaUSA
- Wien Center for Alzheimer's Disease and Memory DisordersMount Sinai, Medical CenterNew YorkUSA
| | - Ranjan Duara
- 1Florida Alzheimer's Disease Research CenterGainesvilleFloridaUSA
- Wien Center for Alzheimer's Disease and Memory DisordersMount Sinai, Medical CenterNew YorkUSA
| | - David A. Loewenstein
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral SciencesUniversity of Miami Miller School of MedicineMiamiUSA
- 1Florida Alzheimer's Disease Research CenterGainesvilleFloridaUSA
| |
Collapse
|
16
|
Loewenstein DA, Curiel Cid RE, Kitaigorodsky M, Crocco EA, Zheng DD, Gorman KL. Amnestic Mild Cognitive Impairment is Characterized by the Inability to Recover from Proactive Semantic Interference across Multiple Learning Trials. JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE 2021; 8:181-187. [PMID: 33569565 DOI: 10.14283/jpad.2021.3] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
BACKGROUND Difficulties in inhibition and self-monitoring are early features of incipient Alzheimer's disease and may manifest as susceptibility to proactive semantic interference. However, due to limitations of traditional memory assessment paradigms, recovery from interference effects following repeated learning opportunities has not been explored. OBJECTIVE This study employed a novel computerized list learning test consisting of repeated learning trials to assess recovery from proactive and retroactive semantic interference. DESIGN The design was cross-sectional. SETTING Participants were recruited from the community as part of a longitudinal study on normal and abnormal aging. PARTICIPANTS The sample consisted of 46 cognitively normal individuals and 30 participants with amnestic mild cognitive impairment. MEASUREMENTS Participants were administered the Cognitive Stress Test and traditional neuropsychological measures. Step-wise logistic regression was applied to determine which Cognitive Stress Test measures best discriminated between diagnostic groups. This was followed by receiver operating characteristic analyses. RESULTS Cued A3 recall, Cued B3 recall and Cued B2 intrusions were all independent predictors of diagnostic status. The overall predictive utility of the model yielded 75.9% sensitivity, 91.1% specificity, and an overall correct classification rate of 85.1%. When these variables were jointly entered into receiver operating characteristic analyses, the area under the curve was .923 (p<.001). CONCLUSIONS This novel paradigm's use of repeated learning trials offers a unique opportunity to assess recovery from proactive and retroactive semantic interference. Participants with mild cognitive impairment exhibited a continued failure to recover from proactive interference that could not be explained by mere learning deficits.
Collapse
Affiliation(s)
- D A Loewenstein
- David A. Loewenstein, PhD, ABPP-CN; Director, Center for Cognitive Neuroscience and Aging; Professor of Psychiatry and Behavioral Sciences; Professor of Neurology; University of Miami, 1695 NW 9th Ave, Suite 3202, Miami, FL 33136; ; Phone: (305) 355-7016; Fax: (305) 255-9076
| | | | | | | | | | | |
Collapse
|
17
|
Crocco EA, Curiel RE, Kitaigorodsky M, Grau GA, Garcia JM, Duara R, Barker W, Chirinos CL, Rodriguez R, Loewenstein DA. Intrusion Errors and Progression of Cognitive Deficits in Older Adults with Mild Cognitive Impairment and PreMCI States. Dement Geriatr Cogn Disord 2021; 50:135-142. [PMID: 34161947 PMCID: PMC8376744 DOI: 10.1159/000512804] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/30/2020] [Accepted: 11/03/2020] [Indexed: 01/06/2023] Open
Abstract
INTRODUCTION Among persons with amnestic mild cognitive impairment (aMCI), intrusion errors on subscales that measure proactive semantic interference (PSI) may be among the earliest behavioral markers of elevated Alzheimer's disease brain pathology. While there has been considerable cross-sectional work in the area, it is presently unknown whether semantic intrusion errors are predictive of progression of cognitive impairment in aMCI or PreMCI (not cognitively normal but not meeting full criteria for MCI). METHODS This study examined the extent to which the percentage of semantic intrusion errors (PIE) based on total responses on a novel cognitive stress test, the Loewenstein-Acevedo Scales for Semantic Interference and Learning (LASSI-L), could predict clinical/cognitive outcomes over an average 26-month period in older adults initially diagnosed with aMCI, PreMCI, and normal cognition. RESULTS On the LASSI-L subscale sensitive to PSI, a PIE cut point of 44% intrusion errors distinguished between those at-risk individuals with PreMCI who progressed to MCI over time compared to individuals with PreMCI who reverted to normal on longitudinal follow-up. Importantly, PIE was able to accurately predict 83.3% of aMCI individuals who later progressed to dementia. DISCUSSION These preliminary findings indicate that PIE on LASSI-L subscales that measure PSI may be a useful predictor of clinical progression overtime in at-risk older adults.
Collapse
Affiliation(s)
- Elizabeth A. Crocco
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, 1695 NW 9 Avenue, Miami, Florida, 33136. U.S.A
| | - Rosie E. Curiel
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, 1695 NW 9 Avenue, Miami, Florida, 33136. U.S.A.,Corresponding Author: Rosie E. Curiel Cid, Psy.D., Associate Professor and Neuropsychologist, University of Miami Miller School of Medicine, 1695 NW 9 Avenue, Suite 3202, Miami, FL 33136.,
| | - Marcela Kitaigorodsky
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, 1695 NW 9 Avenue, Miami, Florida, 33136. U.S.A
| | - Gabriella A. Grau
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, 1695 NW 9 Avenue, Miami, Florida, 33136. U.S.A
| | - Jessica M. Garcia
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, 1695 NW 9 Avenue, Miami, Florida, 33136. U.S.A
| | - Ranjan Duara
- Wien Center for Alzheimer’s Disease and Memory Disorders, Mount Sinai Medical Center, 4300 Alton Road, Miami Beach, Florida 33140, U.S.A
| | - Warren Barker
- Wien Center for Alzheimer’s Disease and Memory Disorders, Mount Sinai Medical Center, 4300 Alton Road, Miami Beach, Florida 33140, U.S.A
| | - Cesar L. Chirinos
- Wien Center for Alzheimer’s Disease and Memory Disorders, Mount Sinai Medical Center, 4300 Alton Road, Miami Beach, Florida 33140, U.S.A
| | - Rosemarie Rodriguez
- Wien Center for Alzheimer’s Disease and Memory Disorders, Mount Sinai Medical Center, 4300 Alton Road, Miami Beach, Florida 33140, U.S.A
| | - David A. Loewenstein
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, 1695 NW 9 Avenue, Miami, Florida, 33136. U.S.A
| |
Collapse
|
18
|
Capp KE, Curiel Cid RE, Crocco EA, Stripling A, Kitaigorodsky M, Sierra LA, Melo JG, Loewenstein DA. Semantic Intrusion Error Ratio Distinguishes Between Cognitively Impaired and Cognitively Intact African American Older Adults. J Alzheimers Dis 2020; 73:785-790. [PMID: 31884484 DOI: 10.3233/jad-191022] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
BACKGROUND Semantic intrusion errors on memory tests may represent very early cognitive changes associated with elevated Alzheimer's disease pathology within the brain, including amyloid-β (Aβ). Subscales that measure proactive semantic interference (PSI) and intrusions related to PSI on the Loewenstein Acevedo Scales of Semantic Interference and Learning (LASSI-L) have been associated with high levels of brain amyloid load, structural changes on brain MRI in Hispanic and non-Hispanic groups. It is presently unknown whether intrusion errors or other measures of the LASSI-L can differentiate between African-American (AA) older adults diagnosed with amnestic mild cognitive impairment (aMCI) or classified as cognitively normal (CN). OBJECTIVE This study examined the extent to which a high percentage of semantic intrusion errors on LASSI-L subscales susceptible to PSI and other LASSI-L measures could differentiate between AA aMCI and CN groups. METHODS Forty-eight AA older adults were recruited (27 CN and 21 aMCI) and received a through clinical and neuropsychological evaluation. The LASSI-L was administered independent of diagnostic classification. RESULTS With and without statistical adjustment for literacy, AA aMCI participants scored lower on all LASSI-L measures. ROC analyses revealed an area under the curve exceeding 90% and correctly classified 86% of AA aMCI with 82% specificity for AA CN participants. CONCLUSIONS Percentage of intrusion errors on the LASSI-L subscales susceptible to PSI differentiated AA aMCI from AA CN. This adds to emerging evidence indicating that the LASSI-L may be culturally appropriate and can differentiate between aMCI and CN in diverse ethnic/cultural groups.
Collapse
Affiliation(s)
| | - Rosie E Curiel Cid
- Department of Psychiatry and Behavioral Sciences, Center for Cognitive Neuroscience and Aging, University of Miami Miller School of Medicine, Miami, FL, USA
| | - Elizabeth A Crocco
- Department of Psychiatry and Behavioral Sciences, Center for Cognitive Neuroscience and Aging, University of Miami Miller School of Medicine, Miami, FL, USA
| | | | - Marcela Kitaigorodsky
- Department of Psychiatry and Behavioral Sciences, Center for Cognitive Neuroscience and Aging, University of Miami Miller School of Medicine, Miami, FL, USA
| | - Luis A Sierra
- Department of Psychiatry and Behavioral Sciences, Center for Cognitive Neuroscience and Aging, University of Miami Miller School of Medicine, Miami, FL, USA
| | - Jose G Melo
- Department of Psychiatry and Behavioral Sciences, Center for Cognitive Neuroscience and Aging, University of Miami Miller School of Medicine, Miami, FL, USA
| | - David A Loewenstein
- Department of Psychiatry and Behavioral Sciences, Center for Cognitive Neuroscience and Aging, University of Miami Miller School of Medicine, Miami, FL, USA
| |
Collapse
|
19
|
Crocco E, Curiel-Cid RE, Kitaigorodsky M, González-Jiménez CJ, Zheng D, Duara R, Loewenstein DA. A Brief Version of the LASSI-L Detects Prodromal Alzheimer's Disease States. J Alzheimers Dis 2020; 78:789-799. [PMID: 33074233 DOI: 10.3233/jad-200790] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
BACKGROUND The Loewenstein-Acevedo Scales for Semantic Interference and Learning (LASSI-L) is an increasingly utilized cognitive stress test designed to identify early cognitive changes associated with incipient neurodegenerative disease. OBJECTIVE To examine previously derived cut-points for cognitively unimpaired older adults that were suggestive of performance impairment on multiple subscales of the LASSI-L. These cut-points were applied to a new sample of older adults who were cognitive healthy controls (HC: n = 26) and those on the Alzheimer's disease (AD) continuum from early stage mild cognitive impairment (EMCI: n = 28), late stage MCI (LMCI: n = 18) to mild AD (AD: n = 27). METHODS All participants were administered the LASSI-L. All cognitively impaired participants were PET amyloid positive which likely reflects underlying AD neuropathology, while cognitively normal counterparts were deemed to have amyloid negative scans. RESULTS There was a monotonic relationship between the number of deficits on LASSI-L subscales and independent classification of study groups with greater severity of cognitive impairment. Importantly, taken together, impairment on maximum learning ability and measures of proactive semantic interference (both reflected by cued recall and intrusion errors) correctly classified 74.1% of EMCI, 94.4% of LMCI, and 96.3% of AD. Only 7.7% of HC were incorrectly classified as having impairments. CONCLUSION A modest number of LASSI-L subscales taking approximately 8 minutes to administer, had excellent discriminative ability using established cut-offs among individuals with presumptive stages of AD. This has potential implications for both clinical practice and clinical research settings targeting AD during early prodromal stages.
Collapse
Affiliation(s)
- Elizabeth Crocco
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.,1Florida Alzheimer's Disease Research Center, Miami, FL, USA
| | - Rosie E Curiel-Cid
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.,1Florida Alzheimer's Disease Research Center, Miami, FL, USA
| | - Marcela Kitaigorodsky
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA
| | - Christian J González-Jiménez
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA
| | - Diane Zheng
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA
| | - Ranjan Duara
- 1Florida Alzheimer's Disease Research Center, Miami, FL, USA.,Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center, Miami, FL, USA
| | - David A Loewenstein
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.,1Florida Alzheimer's Disease Research Center, Miami, FL, USA
| |
Collapse
|
20
|
Matias-Guiu JA, Cortés-Martínez A, Curiel RE, Delgado-Álvarez A, Fernández-Oliveira A, Pytel V, Montero P, Moreno-Ramos T, Loewenstein DA, Matías-Guiu J. Memory Impairment in Relapsing-Remitting Multiple Sclerosis Using a Challenging Semantic Interference Task. Front Neurol 2020; 11:309. [PMID: 32373060 PMCID: PMC7186484 DOI: 10.3389/fneur.2020.00309] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2020] [Accepted: 03/31/2020] [Indexed: 11/13/2022] Open
Abstract
Objective: Episodic memory is frequently impaired in Multiple Sclerosis (MS), but the cognitive characteristics and neuropsychological processes involved remain controversial. Our aim was to study episodic memory dysfunction in MS, using the LASSI-L, a novel memory-based cognitive stress test that uses a new paradigm that capitalizes on semantic interference. Methods: Cross-sectional study in which 93 patients with MS (relapsing-remitting) and 124 healthy controls were included. The LASSI-L test was administered to all participants, as well as a comprehensive neuropsychological battery including a selective reminding test. MS patients were divided into two groups, with cognitive impairment (CI-MS) and cognitively preserved (CP-MS). Results: Reliability of the LASSI-L test was high (Cronbach's alpha 0.892) and there were less ceiling effects. MS patients scored lower than controls on all LASSI-L subtests, except for maximum storage of the initial target items (CRA2). Effect sizes were moderate-large. A delay in learning, difficulties in retroactive semantic interference, failure to recover from proactive semantic interference, and delayed recall were the most frequent findings in MS patients. Scores associated with maximum storage capacity, and retroactive semantic interference were the most strongly associated with cognitive impairment and employment status. Conclusion: We found that deficits in maximum learning, difficulties in recovery from the effects of proactive semantic interference and retroactive semantic interference are three important breakdowns in episodic memory deficits among patients with MS. The LASSI-L showed good psychometric and diagnostic properties. Overall, our study supports the utility of the LASSI-L, as a new cognitive test, useful for neuropsychological assessment in MS in clinical and research settings.
Collapse
Affiliation(s)
- Jordi A Matias-Guiu
- Department of Neurology, Hospital Clinico San Carlos, Health Research Institute "San Carlos" (IdISCC), Universidad Complutense de Madrid, Madrid, Spain
| | - Ana Cortés-Martínez
- Department of Neurology, Hospital Clinico San Carlos, Health Research Institute "San Carlos" (IdISCC), Universidad Complutense de Madrid, Madrid, Spain
| | - Rosie E Curiel
- Department of Psychiatry and Behavioral Sciences, Center for Cognitive Neuroscience and Aging, Miller School of Medicine, University of Miami, Miami, FL, United States
| | - Alfonso Delgado-Álvarez
- Department of Neurology, Hospital Clinico San Carlos, Health Research Institute "San Carlos" (IdISCC), Universidad Complutense de Madrid, Madrid, Spain
| | | | - Vanesa Pytel
- Department of Neurology, Hospital Clinico San Carlos, Health Research Institute "San Carlos" (IdISCC), Universidad Complutense de Madrid, Madrid, Spain
| | - Paloma Montero
- Department of Neurology, Hospital Clinico San Carlos, Health Research Institute "San Carlos" (IdISCC), Universidad Complutense de Madrid, Madrid, Spain
| | - Teresa Moreno-Ramos
- Department of Neurology, Hospital Clinico San Carlos, Health Research Institute "San Carlos" (IdISCC), Universidad Complutense de Madrid, Madrid, Spain
| | - David A Loewenstein
- Department of Psychiatry and Behavioral Sciences, Center for Cognitive Neuroscience and Aging, Miller School of Medicine, University of Miami, Miami, FL, United States
| | - Jorge Matías-Guiu
- Department of Neurology, Hospital Clinico San Carlos, Health Research Institute "San Carlos" (IdISCC), Universidad Complutense de Madrid, Madrid, Spain
| |
Collapse
|
21
|
Curiel Cid RE, Crocco EA, Duara R, Garcia JM, Rosselli M, DeKosky ST, Smith G, Bauer R, Chirinos CL, Adjouadi M, Barker W, Loewenstein DA. A novel method of evaluating semantic intrusion errors to distinguish between amyloid positive and negative groups on the Alzheimer's disease continuum. J Psychiatr Res 2020; 124:131-136. [PMID: 32146222 PMCID: PMC10026350 DOI: 10.1016/j.jpsychires.2020.02.008] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/31/2019] [Revised: 02/07/2020] [Accepted: 02/08/2020] [Indexed: 11/23/2022]
Abstract
BACKGROUND The development and validation of clinical outcome measures to detect early cognitive decline associated with Alzheimer's disease (AD) biomarkers is imperative. Semantic intrusions on the Loewenstein Acevedo Scales of Semantic Interference and Learning (LASSI-L) has outperformed widely used cognitive measures as an early correlate of elevated brain amyloid in prodromal AD and has distinguished those with amnestic mild cognitive impairment (aMCI) and high amyloid load from aMCI attributable to other non-AD conditions. METHODS Since intrusion errors on memory tasks vary widely, we employed a novel method that accounts for the percentage of intrusion errors (PIE) in relation to total responses. Individuals with either high or low amyloid load across the spectrum of aMCI and dementia and amyloid negative cognitively normal older adults (CN) were studied. RESULTS Mean PIE on indices sensitive to proactive semantic interference (PSI) and failure to recover from proactive semantic interference (frPSI) could distinguish amyloid positive from amyloid negative aMCI and dementia groups. Number of correct responses alone, while able to differentiate the different diagnostic groups, did not differentiate amyloid positive aMCI from their counterparts without amyloid pathology. CONCLUSIONS PIE, a novel and sensitive index of early memory dysfunction, demonstrated high levels of sensitivity and specificity in differentiating CN from amyloid positive persons with preclinical AD. Mean levels of PIE are higher for amyloid positive aMCI and dementia participants relative to their amyloid negative counterparts.
Collapse
Affiliation(s)
- Rosie E Curiel Cid
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, 1695 NW 9th Avenue, Miami, FL, 33136, USA.
| | - Elizabeth A Crocco
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, 1695 NW 9th Avenue, Miami, FL, 33136, USA
| | - Ranjan Duara
- Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center, 4300 Alton Road, Miami Beach, FL, 33140, USA
| | - Jessica M Garcia
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, 1695 NW 9th Avenue, Miami, FL, 33136, USA
| | - Monica Rosselli
- Department of Psychology, Florida Atlantic University, 777 Glades Road, Boca Raton, FL, 33431, USA
| | - Steven T DeKosky
- Department of Neurology and McKnight Brain Institute, University of Florida, 1149 Newell Drive Bldg. 59, Rm L5-101, Gainesville, FL, 32611, USA
| | - Glenn Smith
- Department of Clinical and Health Psychology, University of Florida, 1225 Center Dr., RM 3154, Gainesville, FL, 32606, USA
| | - Russell Bauer
- Department of Neurology and McKnight Brain Institute, University of Florida, 1149 Newell Drive Bldg. 59, Rm L5-101, Gainesville, FL, 32611, USA
| | - Cesar L Chirinos
- Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center, 4300 Alton Road, Miami Beach, FL, 33140, USA
| | - Malek Adjouadi
- Center for Advanced Technology and Education, Florida International University, 10555 West Flagler Street, EC 2220, Miami, FL, 33174, USA
| | - Warren Barker
- Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center, 4300 Alton Road, Miami Beach, FL, 33140, USA
| | - David A Loewenstein
- Center for Cognitive Neuroscience and Aging, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, 1695 NW 9th Avenue, Miami, FL, 33136, USA
| |
Collapse
|
22
|
Sánchez SM, Duarte-Abritta B, Abulafia C, De Pino G, Bocaccio H, Castro MN, Sevlever GE, Fonzo GA, Nemeroff CB, Gustafson DR, Guinjoan SM, Villarreal MF. White matter fiber density abnormalities in cognitively normal adults at risk for late-onset Alzheimer's disease. J Psychiatr Res 2020; 122:79-87. [PMID: 31931231 DOI: 10.1016/j.jpsychires.2019.12.019] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/02/2019] [Accepted: 12/30/2019] [Indexed: 12/13/2022]
Abstract
Tau accumulation affecting white matter tracts is an early neuropathological feature of late-onset Alzheimer's disease (LOAD). There is a need to ascertain methods for the detection of early LOAD features to help with disease prevention efforts. The microstructure of these tracts and anatomical brain connectivity can be assessed by analyzing diffusion MRI (dMRI) data. Considering that family history increases the risk of developing LOAD, we explored the microstructure of white matter through dMRI in 23 cognitively normal adults who are offspring of patients with Late-Onset Alzheimer's Disease (O-LOAD) and 22 control subjects (CS) without family history of AD. We also evaluated the relation of white matter microstructure metrics with cortical thickness, volumetry, in vivo amyloid deposition (with the help of PiB positron emission tomography -PiB-PET) and regional brain metabolism (as FDG-PET) measures. Finally we studied the association between cognitive performance and white matter microstructure metrics. O-LOAD exhibited lower fiber density and fractional anisotropy in the posterior portion of the corpus callosum and right fornix when compared to CS. Among O-LOAD, reduced fiber density was associated with lower amyloid deposition in the right hippocampus, and greater cortical thickness in the left precuneus, while higher mean diffusivity was related with greater cortical thickness of the right superior temporal gyrus. Additionally, compromised white matter microstructure was associated with poorer semantic fluency. In conclusion, white matter microstructure metrics may reveal early differences in O-LOAD by virtue of parental history of the disorder, when compared to CS without a family history of LOAD. We demonstrate that these differences are associated with lower fiber density in the posterior portion of the corpus callosum and the right fornix.
Collapse
Affiliation(s)
- Stella M Sánchez
- Grupo de Investigación en Neurociencias Aplicadas a las Alteraciones de la Conducta, Instituto de Neurociencias FLENI-CONICET, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina; Departamento de Física, Facultad de Cs. Exactas y Naturales, Universidad de Buenos Aires, Argentina
| | - Bárbara Duarte-Abritta
- Grupo de Investigación en Neurociencias Aplicadas a las Alteraciones de la Conducta, Instituto de Neurociencias FLENI-CONICET, Argentina
| | - Carolina Abulafia
- Grupo de Investigación en Neurociencias Aplicadas a las Alteraciones de la Conducta, Instituto de Neurociencias FLENI-CONICET, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina; Institute for Biomedical Research (BIOMED), Pontifical Catholic University of Argentina, Argentina
| | - Gabriela De Pino
- Grupo de Investigación en Neurociencias Aplicadas a las Alteraciones de la Conducta, Instituto de Neurociencias FLENI-CONICET, Argentina; Escuela de Ciencia y Tecnología, Universidad Nacional de San Martín, Argentina; Laboratorio de Neuroimágenes, Departamento de Imágenes, Fundación FLENI, Argentina
| | - Hernan Bocaccio
- Grupo de Investigación en Neurociencias Aplicadas a las Alteraciones de la Conducta, Instituto de Neurociencias FLENI-CONICET, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina; Departamento de Física, Facultad de Cs. Exactas y Naturales, Universidad de Buenos Aires, Argentina
| | - Mariana N Castro
- Grupo de Investigación en Neurociencias Aplicadas a las Alteraciones de la Conducta, Instituto de Neurociencias FLENI-CONICET, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina; Departamento de Fisiología, Facultad de Medicina, Universidad de Buenos Aires, Argentina; Departamento de Salud Mental, Facultad de Medicina, Universidad de Buenos Aires, Argentina
| | - Gustavo E Sevlever
- Departamento de Neuropatología y Biología Molecular, Fundación FLENI, Argentina
| | - Greg A Fonzo
- Institute of Early Life Adversity Research, Department of Psychiatry, University of Texas at Austin, United States
| | - Charles B Nemeroff
- Institute of Early Life Adversity Research, Department of Psychiatry, University of Texas at Austin, United States
| | - Deborah R Gustafson
- Department of Neurology, State University of New York University Downstate Medical Center, United States; Department of Health and Education, University of Skövde, Sweden
| | - Salvador M Guinjoan
- Grupo de Investigación en Neurociencias Aplicadas a las Alteraciones de la Conducta, Instituto de Neurociencias FLENI-CONICET, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina; Departamento de Fisiología, Facultad de Medicina, Universidad de Buenos Aires, Argentina; Departamento de Salud Mental, Facultad de Medicina, Universidad de Buenos Aires, Argentina; Servicio de Psiquiatría, Fundación FLENI, Argentina; Neurofisiología I, Facultad de Psicología, Universidad de Buenos Aires, Argentina.
| | - Mirta F Villarreal
- Grupo de Investigación en Neurociencias Aplicadas a las Alteraciones de la Conducta, Instituto de Neurociencias FLENI-CONICET, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina; Departamento de Física, Facultad de Cs. Exactas y Naturales, Universidad de Buenos Aires, Argentina
| |
Collapse
|
23
|
Curiel Cid RE, Loewenstein DA, Rosselli M, Matias-Guiu JA, Piña D, Adjouadi M, Cabrerizo M, Bauer RM, Chan A, DeKosky ST, Golde T, Greig-Custo MT, Lizarraga G, Peñate A, Duara R. A cognitive stress test for prodromal Alzheimer's disease: Multiethnic generalizability. ALZHEIMER'S & DEMENTIA (AMSTERDAM, NETHERLANDS) 2019; 11:550-559. [PMID: 31417955 PMCID: PMC6691954 DOI: 10.1016/j.dadm.2019.05.003] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
INTRODUCTION Culturally fair cognitive assessments sensitive to detecting changes associated with prodromal Alzheimer's disease are needed. METHODS Performance of Hispanic and non-Hispanic older adults on the Loewenstein-Acevedo Scale of Semantic Interference and Learning (LASSI-L) was examined in persons with amnestic mild cognitive impairment (aMCI) or normal cognition. The association between a novel cognitive marker, the failure to recover from proactive semantic interference (frPSI), and cortical thinning was explored. RESULTS English-speaking aMCI participants scored lower than cognitively normal participants on all LASSI-L indices, while Spanish-speaking aMCI participants scored lower in learning, frPSI, and delayed recall. Healthy controls obtained equivalent scores on all indices except retroactive semantic interference. English-speaking and Spanish-speaking aMCI participants had equivalent scores except English speaker's greater vulnerability to frPSI. Across aMCI groups, frPSI was associated with cortical thinning of the entorhinal cortex and precuneus (r = -0.45 to r = 0.52; P < .005). DISCUSSION In diverse populations, LASSI-L performance differentiated patients with aMCI from cognitively normal older adults and was associated with thinning in Alzheimer's disease-prone regions, suggesting its clinical utility.
Collapse
Affiliation(s)
- Rosie E. Curiel Cid
- Department of Psychiatry and Behavioral Sciences, Center for Cognitive Neuroscience and Aging, University of Miami Miller School of Medicine, Miami, FL, USA
| | - David A. Loewenstein
- Department of Psychiatry and Behavioral Sciences, Center for Cognitive Neuroscience and Aging, University of Miami Miller School of Medicine, Miami, FL, USA
| | - Monica Rosselli
- Department of Psychology, Florida Atlantic University, Boca Raton, FL, USA
| | - Jordi A. Matias-Guiu
- Department of Neurology, San Carlos Research Health Institute (Hospital Clínico San Carlos, IdISSC), Universidad Complutense, Madrid, Spain
| | - Daema Piña
- Department of Psychiatry and Behavioral Sciences, Center for Cognitive Neuroscience and Aging, University of Miami Miller School of Medicine, Miami, FL, USA
| | - Malek Adjouadi
- Center for Advanced Technology and Education, Florida International University, Miami, FL, USA
| | - Mercedes Cabrerizo
- Center for Advanced Technology and Education, Florida International University, Miami, FL, USA
| | - Russell M. Bauer
- Department of Neurology and McKnight Brain Institute, University of Florida, Gainesville, FL, USA
| | - Aldrich Chan
- Department of Psychiatry and Behavioral Sciences, Center for Cognitive Neuroscience and Aging, University of Miami Miller School of Medicine, Miami, FL, USA
| | - Steven T. DeKosky
- Department of Neurology and McKnight Brain Institute, University of Florida, Gainesville, FL, USA
| | - Todd Golde
- Department of Neurology and McKnight Brain Institute, University of Florida, Gainesville, FL, USA
| | - Maria T. Greig-Custo
- Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center, Miami Beach, FL, USA
| | - Gabriel Lizarraga
- Center for Advanced Technology and Education, Florida International University, Miami, FL, USA
| | - Ailyn Peñate
- Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center, Miami Beach, FL, USA
| | - Ranjan Duara
- Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center, Miami Beach, FL, USA
| |
Collapse
|
24
|
Cai ZY, Wang CL, Lu TT, Yang WM. Berberine Alleviates Amyloid-beta Pathogenesis Via Activating LKB1/AMPK Signaling in the Brain of APP/PS1 Transgenic Mice. Curr Mol Med 2019; 19:342-348. [PMID: 30873920 DOI: 10.2174/1566524019666190315164120] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2018] [Revised: 03/05/2019] [Accepted: 03/08/2019] [Indexed: 12/18/2022]
Abstract
Background:Liver kinase B1 (LKB1)/5’-adenosine monophosphate-activated protein kinase (AMPK) signaling, a metabolic checkpoint, plays a neuro-protective role in the pathogenesis of Alzheimer’s disease (AD). Amyloid-β (Aβ) acts as a classical biomarker of AD. The aim of the present study was to explore whether berberine (BBR) activates LKB1/AMPK signaling and ameliorates Aβ pathology.Methods:The Aβ levels were detected using enzyme-linked immunosorbent assay and immunohistochemistry. The following biomarkers were measured by Western blotting: phosphorylated (p-) LKB1 (Ser334 and Thr189), p-AMPK (AMPKα and AMPKβ1), synaptophysin, post-synaptic density protein 95 and p-cAMP-response element binding protein (p-CREB). The glial fibrillary acidic protein (GFAP) was determined using Western blotting and immunohistochemistry.Results:BBR inhibited Aβ expression in the brain of APP/PS1 mice. There was a strong up-regulation of both p-LKB1 (Ser334 and Thr189) and p-AMPK (AMPKα and AMPKβ1) in the brains of APP/PS1 transgenic mice after BBR-treatment (P<0.01). BBR promoted the expression of synaptophysin, post-synaptic density protein 95 and p-CREB(Ser133) in the AD brain, compared with the model mice.Conclusion:BBR alleviates Aβ pathogenesis and rescues synapse damage via activating LKB1/AMPK signaling in the brain of APP/PS1 transgenic mice.
Collapse
Affiliation(s)
- Zhi-You Cai
- Department of Neurology, Chongqing General Hospital, University of Chinese Academy of Sciences, Chongqing, 400013, Chongqing, China
| | - Chuan-Ling Wang
- Department of Pathology, Chongqing Medical University, Chongqing, 400010, Chongqing, China
| | - Tao-Tao Lu
- Department of Neurology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, 230031 Anhui Province, China
| | - Wen-Ming Yang
- Department of Neurology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, 230031 Anhui Province, China
| |
Collapse
|
25
|
Abulafia C, Fiorentini L, Loewenstein DA, Curiel-Cid R, Sevlever G, Nemeroff CB, Villarreal MF, Vigo DE, Guinjoan SM. Executive functioning in cognitively normal middle-aged offspring of late-onset Alzheimer's disease patients. J Psychiatr Res 2019; 112:23-29. [PMID: 30836202 DOI: 10.1016/j.jpsychires.2019.02.016] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/13/2018] [Revised: 02/18/2019] [Accepted: 02/21/2019] [Indexed: 10/27/2022]
Abstract
Episodic memory deficits are traditionally seen as the hallmark cognitive impairment during the prodromal continuum of late-onset Alzheimer's disease (LOAD). Previous studies identified early brain alterations in regions subserving executive functions in asymptomatic, middle-aged offspring of patients with LOAD (O-LOAD), suggesting that premature episodic memory deficits could be associated to executive dysfunction in this model. We hypothesized that O-LOAD would exhibit reduced executive performance evidenced by increased errors and decreased strategy use on an episodic memory task. We assessed 32 asymptomatic middle-aged O-LOAD and 28 age-equivalent control subjects (CS) with several tests that measure executive functions and the Rey Auditory Verbal Learning Test (RAVLT) to measure memory performance. All tests were scored using both traditional and process scores (quantification of errors and strategies underlying overall performance). T-tests were used to compare performance between both groups and Spearman correlations were implemented to measure associations between variables. O-LOAD participants exhibited decreased executive performance compared to CS as it relates to initiation time (Tower of London), mental switching (Trail Making Test B), and interference effects (Stroop Word-Color condition). Traditional RAVLT measures showed a poorer performance by O-LOAD and RAVLT process scores revealed increased interference effects on this group. Positive correlations (rs) were found between the executive measures and several RAVLT measures for O-LOAD but not for CS. In conclusion, O-LOAD participants exhibited early subtle cognitive changes in executive processing. Observed memory difficulties may be associated in part to executive deficits suggesting an interplay between memory and executive functions. Process score impairments were observed earlier than clinical decline on neuropsychological scores in this at-risk cohort and might be useful cognitive markers of preclinical LOAD.
Collapse
Affiliation(s)
- Carolina Abulafia
- Grupo de Investigación en Neurociencias Aplicadas a las Alteraciones de la Conducta. FLENI, Buenos Aires, Argentina; Servicio de Psiquiatría. FLENI, Buenos Aires, Argentina
| | - Leticia Fiorentini
- Grupo de Investigación en Neurociencias Aplicadas a las Alteraciones de la Conducta. FLENI, Buenos Aires, Argentina; National Council for Scientific and Technological Research (CONICET), Argentina; Servicio de Psiquiatría. FLENI, Buenos Aires, Argentina
| | - David A Loewenstein
- Department of Psychiatry and Behavioral Sciences and Center on Aging, Miller School of Medicine, University of Miami, USA
| | - Rosie Curiel-Cid
- Department of Psychiatry and Behavioral Sciences and Center on Aging, Miller School of Medicine, University of Miami, USA
| | - Gustavo Sevlever
- Departamento de Neuropatología y Biología Molecular. FLENI, Buenos Aires, Argentina; Departamento de Docencia e Investigación. FLENI, Buenos Aires, Argentina
| | - Charles B Nemeroff
- Institute of Early Life Adversity Research, Dell Medical School, The University of Texas, Austin, USA
| | - Mirta F Villarreal
- Grupo de Investigación en Neurociencias Aplicadas a las Alteraciones de la Conducta. FLENI, Buenos Aires, Argentina; National Council for Scientific and Technological Research (CONICET), Argentina; Department of Physics (FCEyN), University of Buenos Aires, Argentina
| | - Daniel E Vigo
- National Council for Scientific and Technological Research (CONICET), Argentina; Institute for Biomedical Research (BIOMED), School of Medical Sciences, Universidad Católica Argentina, Buenos Aires, Argentina; School of Psychology and Educational Sciences, Katholieke Universiteit Leuven, Belgium
| | - Salvador M Guinjoan
- Grupo de Investigación en Neurociencias Aplicadas a las Alteraciones de la Conducta. FLENI, Buenos Aires, Argentina; National Council for Scientific and Technological Research (CONICET), Argentina; Servicio de Psiquiatría. FLENI, Buenos Aires, Argentina; Departamento de Psiquiatría y Salud Mental, Unidad docente FLENI, Universidad de Buenos Aires, Facultad de Medicina, Argentina.
| |
Collapse
|
26
|
Cortical thickness, brain metabolic activity, and in vivo amyloid deposition in asymptomatic, middle-aged offspring of patients with late-onset Alzheimer's disease. J Psychiatr Res 2018; 107:11-18. [PMID: 30308328 DOI: 10.1016/j.jpsychires.2018.10.008] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/28/2018] [Revised: 08/30/2018] [Accepted: 10/04/2018] [Indexed: 11/20/2022]
Abstract
The natural history of preclinical late-onset Alzheimer's disease (LOAD) remains obscure and has received less attention than that of early-onset AD (EOAD), in spite of accounting for more than 99% of cases of AD. With the purpose of detecting early structural and functional traits associated with the disorder, we sought to characterize cortical thickness and subcortical grey matter volume, cerebral metabolism, and amyloid deposition in persons at risk for LOAD in comparison with a similar group without family history of AD. We obtained 3T T1 images for gray matter volume, FDG-PET to evaluate regional cerebral metabolism, and PET-PiB to detect fibrillar amyloid deposition in 30 middle-aged, asymptomatic, cognitively normal individuals with one parent diagnosed with LOAD (O-LOAD), and 25 comparable controls (CS) without family history of neurodegenerative disorders (CS). We observed isocortical thinning in AD-relevant areas including posterior cingulate, precuneus, and areas of the prefrontal and temporoparietal cortex in O-LOAD. Unexpectedly, this group displayed increased cerebral metabolism, in some cases overlapping with the areas of cortical thinning, and no differences in bilateral hippocampal volume and hippocampal metabolism. Given the importance of age in this sample of individuals potentially developing early AD-related changes, we controlled results for age and observed that most differences in cortical thickness and metabolism became nonsignificant; however, greater deposition of β-amyloid was observed in the right hemisphere including temporoparietal cortex, postcentral gyrus, fusiform inferior and middle temporal and lingual gyri. If replicated, the present observations of morphological, metabolic, and amyloid changes in cognitively normal persons with family history of LOAD may bear important implications for the definition of very early phenotypes of this disorder.
Collapse
|
27
|
Loewenstein DA, Curiel RE, DeKosky S, Bauer RM, Rosselli M, Guinjoan SM, Adjouadi M, Peñate A, Barker WW, Goenaga S, Golde T, Greig-Custo MT, Hanson KS, Li C, Lizarraga G, Marsiske M, Duara R. Utilizing semantic intrusions to identify amyloid positivity in mild cognitive impairment. Neurology 2018; 91:e976-e984. [PMID: 30076274 DOI: 10.1212/wnl.0000000000006128] [Citation(s) in RCA: 47] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2018] [Accepted: 05/31/2018] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE Semantic intrusion (SI) errors may highlight specific breakdowns in memory associated with preclinical Alzheimer disease (AD); however, there have been no investigations to determine whether SI errors occur with greater frequency in persons with amnestic mild cognitive impairment (aMCI) confirmed as amyloid positive (Amy+) vs those who have clinical symptoms of aMCI-AD with negative amyloid scans (suspected non-AD pathology [SNAP]) or persons who are diagnosed with other brain disorders affecting cognition. METHODS Eighty-eight participants with aMCI underwent brain amyloid PET and MRI scans and were classified as early AD (Amy+), SNAP (Amy-), or other neurological/psychiatric diagnosis (Amy-). We focused on SI on the Loewenstein-Acevedo Scales for Semantic Interference and Learning (LASSI-L) targeting proactive semantic interference (PSI; old semantic learning interferes with new semantic learning), failure to recover from PSI after an additional learning trial (frPSI), and retroactive semantic interference (new semantic learning interferes with memory for old semantic learning). RESULTS SIs on measures of PSI and frPSI distinguished between Amy+ AD and SNAP and other non-AD cases. PSI and frPSI intrusions evidenced moderately high associations with reduced volumes in the entorhinal cortex, superior temporal regions, and supramarginal gyrus. No such associations were observed in cases with SNAP. CONCLUSIONS SIs on the LASSI-L related to PSI and frPSI uniquely differentiated Amy+ and Amy- participants with aMCI and likely reflect deficits with inhibition and source memory in preclinical AD not captured by traditional cognitive measures. This may represent a specific, noninvasive test successful at distinguishing cases with true AD from those with SNAP.
Collapse
Affiliation(s)
- David A Loewenstein
- From the Center on Aging (D.A.L., R.E.C.) and Department of Psychiatry and Behavioral Sciences (D.A.L., R.E.C.), University of Miami Miller School of Medicine; Wien Center for Alzheimer's Disease and Memory Disorders (D.A.L., A.P., W.W.B., S.G., M.T.G.-C., R.D.), Mount Sinai Medical Center, Miami Beach; McKnight Brain Institute (S.D.), Department of Neurology (S.D., R.D.), Department of Clinical and Health Psychology (R.M.B.), Center for Translational Research in Neurodegenerative Diseases (T.G.), and Clinical and Translational Science Institute (K.S.H., M.M.), University of Florida, Gainesville; Department of Psychology (M.R.), Florida Atlantic University, Boca Raton; FLENI Foundation (S.M.G.), University of Buenos Aires Schools of Medicine and Psychology, Argentina; Department of Electrical and Computer Engineering (M.A., C.L., G.L.), College of Engineering and Computing, Florida International University Center for Advanced Technology and Education; and Herbert Wertheim College of Medicine (R.D.), Florida International University, Miami.
| | - Rosie E Curiel
- From the Center on Aging (D.A.L., R.E.C.) and Department of Psychiatry and Behavioral Sciences (D.A.L., R.E.C.), University of Miami Miller School of Medicine; Wien Center for Alzheimer's Disease and Memory Disorders (D.A.L., A.P., W.W.B., S.G., M.T.G.-C., R.D.), Mount Sinai Medical Center, Miami Beach; McKnight Brain Institute (S.D.), Department of Neurology (S.D., R.D.), Department of Clinical and Health Psychology (R.M.B.), Center for Translational Research in Neurodegenerative Diseases (T.G.), and Clinical and Translational Science Institute (K.S.H., M.M.), University of Florida, Gainesville; Department of Psychology (M.R.), Florida Atlantic University, Boca Raton; FLENI Foundation (S.M.G.), University of Buenos Aires Schools of Medicine and Psychology, Argentina; Department of Electrical and Computer Engineering (M.A., C.L., G.L.), College of Engineering and Computing, Florida International University Center for Advanced Technology and Education; and Herbert Wertheim College of Medicine (R.D.), Florida International University, Miami
| | - Steven DeKosky
- From the Center on Aging (D.A.L., R.E.C.) and Department of Psychiatry and Behavioral Sciences (D.A.L., R.E.C.), University of Miami Miller School of Medicine; Wien Center for Alzheimer's Disease and Memory Disorders (D.A.L., A.P., W.W.B., S.G., M.T.G.-C., R.D.), Mount Sinai Medical Center, Miami Beach; McKnight Brain Institute (S.D.), Department of Neurology (S.D., R.D.), Department of Clinical and Health Psychology (R.M.B.), Center for Translational Research in Neurodegenerative Diseases (T.G.), and Clinical and Translational Science Institute (K.S.H., M.M.), University of Florida, Gainesville; Department of Psychology (M.R.), Florida Atlantic University, Boca Raton; FLENI Foundation (S.M.G.), University of Buenos Aires Schools of Medicine and Psychology, Argentina; Department of Electrical and Computer Engineering (M.A., C.L., G.L.), College of Engineering and Computing, Florida International University Center for Advanced Technology and Education; and Herbert Wertheim College of Medicine (R.D.), Florida International University, Miami
| | - Russell M Bauer
- From the Center on Aging (D.A.L., R.E.C.) and Department of Psychiatry and Behavioral Sciences (D.A.L., R.E.C.), University of Miami Miller School of Medicine; Wien Center for Alzheimer's Disease and Memory Disorders (D.A.L., A.P., W.W.B., S.G., M.T.G.-C., R.D.), Mount Sinai Medical Center, Miami Beach; McKnight Brain Institute (S.D.), Department of Neurology (S.D., R.D.), Department of Clinical and Health Psychology (R.M.B.), Center for Translational Research in Neurodegenerative Diseases (T.G.), and Clinical and Translational Science Institute (K.S.H., M.M.), University of Florida, Gainesville; Department of Psychology (M.R.), Florida Atlantic University, Boca Raton; FLENI Foundation (S.M.G.), University of Buenos Aires Schools of Medicine and Psychology, Argentina; Department of Electrical and Computer Engineering (M.A., C.L., G.L.), College of Engineering and Computing, Florida International University Center for Advanced Technology and Education; and Herbert Wertheim College of Medicine (R.D.), Florida International University, Miami
| | - Monica Rosselli
- From the Center on Aging (D.A.L., R.E.C.) and Department of Psychiatry and Behavioral Sciences (D.A.L., R.E.C.), University of Miami Miller School of Medicine; Wien Center for Alzheimer's Disease and Memory Disorders (D.A.L., A.P., W.W.B., S.G., M.T.G.-C., R.D.), Mount Sinai Medical Center, Miami Beach; McKnight Brain Institute (S.D.), Department of Neurology (S.D., R.D.), Department of Clinical and Health Psychology (R.M.B.), Center for Translational Research in Neurodegenerative Diseases (T.G.), and Clinical and Translational Science Institute (K.S.H., M.M.), University of Florida, Gainesville; Department of Psychology (M.R.), Florida Atlantic University, Boca Raton; FLENI Foundation (S.M.G.), University of Buenos Aires Schools of Medicine and Psychology, Argentina; Department of Electrical and Computer Engineering (M.A., C.L., G.L.), College of Engineering and Computing, Florida International University Center for Advanced Technology and Education; and Herbert Wertheim College of Medicine (R.D.), Florida International University, Miami
| | - Salvador M Guinjoan
- From the Center on Aging (D.A.L., R.E.C.) and Department of Psychiatry and Behavioral Sciences (D.A.L., R.E.C.), University of Miami Miller School of Medicine; Wien Center for Alzheimer's Disease and Memory Disorders (D.A.L., A.P., W.W.B., S.G., M.T.G.-C., R.D.), Mount Sinai Medical Center, Miami Beach; McKnight Brain Institute (S.D.), Department of Neurology (S.D., R.D.), Department of Clinical and Health Psychology (R.M.B.), Center for Translational Research in Neurodegenerative Diseases (T.G.), and Clinical and Translational Science Institute (K.S.H., M.M.), University of Florida, Gainesville; Department of Psychology (M.R.), Florida Atlantic University, Boca Raton; FLENI Foundation (S.M.G.), University of Buenos Aires Schools of Medicine and Psychology, Argentina; Department of Electrical and Computer Engineering (M.A., C.L., G.L.), College of Engineering and Computing, Florida International University Center for Advanced Technology and Education; and Herbert Wertheim College of Medicine (R.D.), Florida International University, Miami
| | - Malek Adjouadi
- From the Center on Aging (D.A.L., R.E.C.) and Department of Psychiatry and Behavioral Sciences (D.A.L., R.E.C.), University of Miami Miller School of Medicine; Wien Center for Alzheimer's Disease and Memory Disorders (D.A.L., A.P., W.W.B., S.G., M.T.G.-C., R.D.), Mount Sinai Medical Center, Miami Beach; McKnight Brain Institute (S.D.), Department of Neurology (S.D., R.D.), Department of Clinical and Health Psychology (R.M.B.), Center for Translational Research in Neurodegenerative Diseases (T.G.), and Clinical and Translational Science Institute (K.S.H., M.M.), University of Florida, Gainesville; Department of Psychology (M.R.), Florida Atlantic University, Boca Raton; FLENI Foundation (S.M.G.), University of Buenos Aires Schools of Medicine and Psychology, Argentina; Department of Electrical and Computer Engineering (M.A., C.L., G.L.), College of Engineering and Computing, Florida International University Center for Advanced Technology and Education; and Herbert Wertheim College of Medicine (R.D.), Florida International University, Miami
| | - Ailyn Peñate
- From the Center on Aging (D.A.L., R.E.C.) and Department of Psychiatry and Behavioral Sciences (D.A.L., R.E.C.), University of Miami Miller School of Medicine; Wien Center for Alzheimer's Disease and Memory Disorders (D.A.L., A.P., W.W.B., S.G., M.T.G.-C., R.D.), Mount Sinai Medical Center, Miami Beach; McKnight Brain Institute (S.D.), Department of Neurology (S.D., R.D.), Department of Clinical and Health Psychology (R.M.B.), Center for Translational Research in Neurodegenerative Diseases (T.G.), and Clinical and Translational Science Institute (K.S.H., M.M.), University of Florida, Gainesville; Department of Psychology (M.R.), Florida Atlantic University, Boca Raton; FLENI Foundation (S.M.G.), University of Buenos Aires Schools of Medicine and Psychology, Argentina; Department of Electrical and Computer Engineering (M.A., C.L., G.L.), College of Engineering and Computing, Florida International University Center for Advanced Technology and Education; and Herbert Wertheim College of Medicine (R.D.), Florida International University, Miami
| | - William W Barker
- From the Center on Aging (D.A.L., R.E.C.) and Department of Psychiatry and Behavioral Sciences (D.A.L., R.E.C.), University of Miami Miller School of Medicine; Wien Center for Alzheimer's Disease and Memory Disorders (D.A.L., A.P., W.W.B., S.G., M.T.G.-C., R.D.), Mount Sinai Medical Center, Miami Beach; McKnight Brain Institute (S.D.), Department of Neurology (S.D., R.D.), Department of Clinical and Health Psychology (R.M.B.), Center for Translational Research in Neurodegenerative Diseases (T.G.), and Clinical and Translational Science Institute (K.S.H., M.M.), University of Florida, Gainesville; Department of Psychology (M.R.), Florida Atlantic University, Boca Raton; FLENI Foundation (S.M.G.), University of Buenos Aires Schools of Medicine and Psychology, Argentina; Department of Electrical and Computer Engineering (M.A., C.L., G.L.), College of Engineering and Computing, Florida International University Center for Advanced Technology and Education; and Herbert Wertheim College of Medicine (R.D.), Florida International University, Miami
| | - Sindy Goenaga
- From the Center on Aging (D.A.L., R.E.C.) and Department of Psychiatry and Behavioral Sciences (D.A.L., R.E.C.), University of Miami Miller School of Medicine; Wien Center for Alzheimer's Disease and Memory Disorders (D.A.L., A.P., W.W.B., S.G., M.T.G.-C., R.D.), Mount Sinai Medical Center, Miami Beach; McKnight Brain Institute (S.D.), Department of Neurology (S.D., R.D.), Department of Clinical and Health Psychology (R.M.B.), Center for Translational Research in Neurodegenerative Diseases (T.G.), and Clinical and Translational Science Institute (K.S.H., M.M.), University of Florida, Gainesville; Department of Psychology (M.R.), Florida Atlantic University, Boca Raton; FLENI Foundation (S.M.G.), University of Buenos Aires Schools of Medicine and Psychology, Argentina; Department of Electrical and Computer Engineering (M.A., C.L., G.L.), College of Engineering and Computing, Florida International University Center for Advanced Technology and Education; and Herbert Wertheim College of Medicine (R.D.), Florida International University, Miami
| | - Todd Golde
- From the Center on Aging (D.A.L., R.E.C.) and Department of Psychiatry and Behavioral Sciences (D.A.L., R.E.C.), University of Miami Miller School of Medicine; Wien Center for Alzheimer's Disease and Memory Disorders (D.A.L., A.P., W.W.B., S.G., M.T.G.-C., R.D.), Mount Sinai Medical Center, Miami Beach; McKnight Brain Institute (S.D.), Department of Neurology (S.D., R.D.), Department of Clinical and Health Psychology (R.M.B.), Center for Translational Research in Neurodegenerative Diseases (T.G.), and Clinical and Translational Science Institute (K.S.H., M.M.), University of Florida, Gainesville; Department of Psychology (M.R.), Florida Atlantic University, Boca Raton; FLENI Foundation (S.M.G.), University of Buenos Aires Schools of Medicine and Psychology, Argentina; Department of Electrical and Computer Engineering (M.A., C.L., G.L.), College of Engineering and Computing, Florida International University Center for Advanced Technology and Education; and Herbert Wertheim College of Medicine (R.D.), Florida International University, Miami
| | - Maria T Greig-Custo
- From the Center on Aging (D.A.L., R.E.C.) and Department of Psychiatry and Behavioral Sciences (D.A.L., R.E.C.), University of Miami Miller School of Medicine; Wien Center for Alzheimer's Disease and Memory Disorders (D.A.L., A.P., W.W.B., S.G., M.T.G.-C., R.D.), Mount Sinai Medical Center, Miami Beach; McKnight Brain Institute (S.D.), Department of Neurology (S.D., R.D.), Department of Clinical and Health Psychology (R.M.B.), Center for Translational Research in Neurodegenerative Diseases (T.G.), and Clinical and Translational Science Institute (K.S.H., M.M.), University of Florida, Gainesville; Department of Psychology (M.R.), Florida Atlantic University, Boca Raton; FLENI Foundation (S.M.G.), University of Buenos Aires Schools of Medicine and Psychology, Argentina; Department of Electrical and Computer Engineering (M.A., C.L., G.L.), College of Engineering and Computing, Florida International University Center for Advanced Technology and Education; and Herbert Wertheim College of Medicine (R.D.), Florida International University, Miami
| | - Kevin S Hanson
- From the Center on Aging (D.A.L., R.E.C.) and Department of Psychiatry and Behavioral Sciences (D.A.L., R.E.C.), University of Miami Miller School of Medicine; Wien Center for Alzheimer's Disease and Memory Disorders (D.A.L., A.P., W.W.B., S.G., M.T.G.-C., R.D.), Mount Sinai Medical Center, Miami Beach; McKnight Brain Institute (S.D.), Department of Neurology (S.D., R.D.), Department of Clinical and Health Psychology (R.M.B.), Center for Translational Research in Neurodegenerative Diseases (T.G.), and Clinical and Translational Science Institute (K.S.H., M.M.), University of Florida, Gainesville; Department of Psychology (M.R.), Florida Atlantic University, Boca Raton; FLENI Foundation (S.M.G.), University of Buenos Aires Schools of Medicine and Psychology, Argentina; Department of Electrical and Computer Engineering (M.A., C.L., G.L.), College of Engineering and Computing, Florida International University Center for Advanced Technology and Education; and Herbert Wertheim College of Medicine (R.D.), Florida International University, Miami
| | - Chunfei Li
- From the Center on Aging (D.A.L., R.E.C.) and Department of Psychiatry and Behavioral Sciences (D.A.L., R.E.C.), University of Miami Miller School of Medicine; Wien Center for Alzheimer's Disease and Memory Disorders (D.A.L., A.P., W.W.B., S.G., M.T.G.-C., R.D.), Mount Sinai Medical Center, Miami Beach; McKnight Brain Institute (S.D.), Department of Neurology (S.D., R.D.), Department of Clinical and Health Psychology (R.M.B.), Center for Translational Research in Neurodegenerative Diseases (T.G.), and Clinical and Translational Science Institute (K.S.H., M.M.), University of Florida, Gainesville; Department of Psychology (M.R.), Florida Atlantic University, Boca Raton; FLENI Foundation (S.M.G.), University of Buenos Aires Schools of Medicine and Psychology, Argentina; Department of Electrical and Computer Engineering (M.A., C.L., G.L.), College of Engineering and Computing, Florida International University Center for Advanced Technology and Education; and Herbert Wertheim College of Medicine (R.D.), Florida International University, Miami
| | - Gabriel Lizarraga
- From the Center on Aging (D.A.L., R.E.C.) and Department of Psychiatry and Behavioral Sciences (D.A.L., R.E.C.), University of Miami Miller School of Medicine; Wien Center for Alzheimer's Disease and Memory Disorders (D.A.L., A.P., W.W.B., S.G., M.T.G.-C., R.D.), Mount Sinai Medical Center, Miami Beach; McKnight Brain Institute (S.D.), Department of Neurology (S.D., R.D.), Department of Clinical and Health Psychology (R.M.B.), Center for Translational Research in Neurodegenerative Diseases (T.G.), and Clinical and Translational Science Institute (K.S.H., M.M.), University of Florida, Gainesville; Department of Psychology (M.R.), Florida Atlantic University, Boca Raton; FLENI Foundation (S.M.G.), University of Buenos Aires Schools of Medicine and Psychology, Argentina; Department of Electrical and Computer Engineering (M.A., C.L., G.L.), College of Engineering and Computing, Florida International University Center for Advanced Technology and Education; and Herbert Wertheim College of Medicine (R.D.), Florida International University, Miami
| | - Michael Marsiske
- From the Center on Aging (D.A.L., R.E.C.) and Department of Psychiatry and Behavioral Sciences (D.A.L., R.E.C.), University of Miami Miller School of Medicine; Wien Center for Alzheimer's Disease and Memory Disorders (D.A.L., A.P., W.W.B., S.G., M.T.G.-C., R.D.), Mount Sinai Medical Center, Miami Beach; McKnight Brain Institute (S.D.), Department of Neurology (S.D., R.D.), Department of Clinical and Health Psychology (R.M.B.), Center for Translational Research in Neurodegenerative Diseases (T.G.), and Clinical and Translational Science Institute (K.S.H., M.M.), University of Florida, Gainesville; Department of Psychology (M.R.), Florida Atlantic University, Boca Raton; FLENI Foundation (S.M.G.), University of Buenos Aires Schools of Medicine and Psychology, Argentina; Department of Electrical and Computer Engineering (M.A., C.L., G.L.), College of Engineering and Computing, Florida International University Center for Advanced Technology and Education; and Herbert Wertheim College of Medicine (R.D.), Florida International University, Miami
| | - Ranjan Duara
- From the Center on Aging (D.A.L., R.E.C.) and Department of Psychiatry and Behavioral Sciences (D.A.L., R.E.C.), University of Miami Miller School of Medicine; Wien Center for Alzheimer's Disease and Memory Disorders (D.A.L., A.P., W.W.B., S.G., M.T.G.-C., R.D.), Mount Sinai Medical Center, Miami Beach; McKnight Brain Institute (S.D.), Department of Neurology (S.D., R.D.), Department of Clinical and Health Psychology (R.M.B.), Center for Translational Research in Neurodegenerative Diseases (T.G.), and Clinical and Translational Science Institute (K.S.H., M.M.), University of Florida, Gainesville; Department of Psychology (M.R.), Florida Atlantic University, Boca Raton; FLENI Foundation (S.M.G.), University of Buenos Aires Schools of Medicine and Psychology, Argentina; Department of Electrical and Computer Engineering (M.A., C.L., G.L.), College of Engineering and Computing, Florida International University Center for Advanced Technology and Education; and Herbert Wertheim College of Medicine (R.D.), Florida International University, Miami
| |
Collapse
|